ciprofloxacin has been researched along with Osteomyelitis in 178 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Osteomyelitis: INFLAMMATION of the bone as a result of infection. It may be caused by a variety of infectious agents, especially pyogenic (PUS - producing) BACTERIA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The efficacy and safety of three oral fluoroquinolones (lomefloxacin, levofloxacin, and ciprofloxacin) for the treatment of chronic osteomyelitis were analyzed." | 9.09 | Ciprofloxacin, lomefloxacin, or levofloxacin as treatment for chronic osteomyelitis. ( Greenberg, RN; Newman, MT; Pectol, RW; Shariaty, S, 2000) |
| "Oral ciprofloxacin was used at doses ranging from 500 mg to 1500 mg twice daily for 15 to 476 (mean 139) days for treatment of acute or chronic osteomyelitis in 38 patients, and acute arthritis in two." | 9.06 | Therapy of acute and chronic gram-negative osteomyelitis with ciprofloxacin. Report from a Swedish Study Group. ( , 1988) |
| "8 years) with chronic postsurgical osteomyelitis were treated with ciprofloxacin." | 9.06 | Treatment of chronic postsurgical osteomyelitis with ciprofloxacin. ( Hoogkamp-Korstanje, JA, 1987) |
| "Twenty adult patients with chronic contiguous osteomyelitis caused by aerobic gram-negative bacilli were enrolled in an open, prospective cooperative study to determine the effect of oral ciprofloxacin therapy in a dosage of 750 mg every 12 hours." | 9.06 | Oral ciprofloxacin therapy for chronic contiguous osteomyelitis caused by aerobic gram-negative bacilli. ( Craven, PC; Gilbert, DN; Marsh, PK; Preheim, LC; Tice, AD, 1987) |
| "We undertook a prospective, randomized comparison of oral ciprofloxacin with standard parenteral therapies for the treatment of biopsy-proven osteomyelitis caused by susceptible organisms." | 9.06 | Oral ciprofloxacin compared with parenteral antibiotics in the treatment of osteomyelitis. ( Gentry, LO; Rodriguez, GG, 1990) |
| "The efficacy and toxicity of ciprofloxacin, an orally administered fluoroquinolone, were evaluated in 24 infections in 23 patients with osteomyelitis caused by aerobic gram-negative bacilli." | 9.06 | Clinical efficacy of ciprofloxacin therapy for gram-negative bacillary osteomyelitis. ( Boscia, J; Bush, LM; Hessen, MT; Ingerman, MJ; Kaufman, DH; Kaye, D; Korzeniowski, OM; Santoro, J; Topiel, M; Weiner, P, 1987) |
| "The clinical and bacteriological efficacy and safety of ciprofloxacin given as oral doses of 500 to 1,500 mg (normally 750 mg) twice daily for treatment of Gram-negative bacillary osteomyelitis are reviewed." | 8.77 | Ciprofloxacin in the treatment of acute and chronic osteomyelitis: a review. ( Norrby, SR, 1989) |
| "We demonstrate the use of Tc-99m ciprofloxacin imaging in a follow-up case of squamous cell carcinoma of the tongue post hemi-mandibulectomy with clinical suspicion of local recurrence of osteomyelitis." | 7.74 | Diagnosis of mandibular osteomyelitis in probable coexisting tumor recurrence: role of Tc-99m ciprofloxacin imaging. ( Bhatnagar, A; Bhattacharya, A; Gupta, KA; Mittal, BR; Prasad, V; Singh, AK; Singh, B, 2008) |
| "Ciprofloxacin (CFX) implants containing poly(D,L-lactide) and calcium phosphates (tricalcium phosphate and hydroxyapatite) was evaluated in 50 rabbits in an experimental osteomyelitis model." | 7.74 | Efficacy of ciprofloxacin implants in treating experimental osteomyelitis. ( Alvarez, H; Castro, C; Delgado, A; Evora, C; Moujir, L; Perera, A; Sánchez, E; Soriano, I, 2008) |
| "A biodegradable system of poly-D,L-dilactide releasing ciprofloxacin was assessed in a Pseudomonas aeruginosa osteomyelitis model after inoculation of the test pathogen into the left tibia of 76 New Zealand White rabbits; 31 were controls (group A), and 45 were implanted with the polymer at the infection site (group B)." | 7.74 | Local treatment of experimental Pseudomonas aeruginosa osteomyelitis with a biodegradable dilactide polymer releasing ciprofloxacin. ( Andreopoulos, A; Dontas, I; Dounis, E; Giamarellos-Bourboulis, EJ; Giamarellou, H; Kanellakopoulou, K; Karagiannakos, P; Kolia, M; Nakopoulou, L; Thivaios, GC, 2008) |
| "Retrospective evaluation of Tc-99m ciprofloxacin (infection) scintigraphy consecutively performed in a series of patients clinically suspected for peripheral osteomyelitis (OM), spondylodiscitis (SD) and fever of unknown origin (FUO)." | 7.71 | [Tc-99m ciprofloxacin in clinically selected patients for peripheral osteomyelitis, spondylodiscitis and fever of unknown origin--preliminary results]. ( Gallowitsch, HJ; Gomez, I; Heinisch, M; Kresnik, E; Kumnig, G; Lind, P; Mikosch, P, 2002) |
| "This report describes a relapse of Salmonella paratyphi B infection in a child with biliary atresia, following 2 weeks of treatment with ciprofloxacin." | 7.69 | A relapse of paratyphoid fever after treatment with ciprofloxacin in a child with congenital biliary atresia. ( Eltringham, IJ; Ireland, D; Irish, D; Issler, H; Teall, A; Thalange, N, 1997) |
| "The efficacies of the quinolones ciprofloxacin and pefloxacin alone and in combination with rifampin were compared with those of vancomycin alone and in combination with rifampin in a rat model of chronic osteomyelitis caused by methicillin-resistant Staphylococcus aureus." | 7.68 | Comparative efficacies of ciprofloxacin, pefloxacin, and vancomycin in combination with rifampin in a rat model of methicillin-resistant Staphylococcus aureus chronic osteomyelitis. ( Dworkin, R; Kunz, S; Modin, G; Rich, R; Sande, M; Zak, O, 1990) |
| "Twenty-two adult patients with osteomyelitis due to Pseudomonas aeruginosa were enrolled in an open, prospective cooperative study to determine the efficacy of oral ciprofloxacin therapy in a dosage of 750 mg twice a day." | 7.68 | Oral ciprofloxacin treatment of Pseudomonas aeruginosa osteomyelitis. ( Dan, M; Pitlik, S; Raz, R; Siegman-Igra, Y, 1990) |
| "Seventeen adult patients with chronic osteomyelitis were treated with oral ciprofloxacin, 750 mg twice daily." | 7.68 | Oral ciprofloxacin for treatment of chronic osteomyelitis. ( Bortoletto, ML; Brasil Filho, R; Carvalho, MC; Levi, GC; Lobo, IM; Mendonça, JS; Silva, ML; Trevisanello, C; Yamaguti, A, 1993) |
| "A group of fourteen patients who had chronic osteomyelitis and were treated with oral ciprofloxacin was compared with a group of twelve patients of similar age who had chronic osteomyelitis and received standard parenteral antibiotic therapy consisting of nafcillin, clindamycin, and gentamicin, singly or in combination." | 7.68 | Oral ciprofloxacin compared with standard parenteral antibiotic therapy for chronic osteomyelitis in adults. ( Calhoun, J; Cantrell, JS; Mader, JT, 1990) |
| "After induction of experimental polymicrobic osteomyelitis with Staphylococcus epidermidis and Bacteroides thetaiotaomicron (ciprofloxacin MIC, 0." | 7.68 | Effect of ciprofloxacin on experimental osteomyelitis in the rabbit tibia, induced with a mixed infection of Staphylococcus epidermidis and Bacteroides thetaiotaomicron. ( Gill, LR; Hossler, FE; Lambe, DW; Mayberry-Carson, KJ; Tober-Meyer, B, 1990) |
| "A rabbit model for Staphylococcus aureus osteomyelitis was used to compare the results of treatment with A-56619 and A-56620, two new aryl-fluoroquinolones, and nafcillin." | 7.67 | Comparative evaluation of A-56619, A-56620, and nafcillin in the treatment of experimental Staphylococcus aureus osteomyelitis. ( Adams, KR; Mader, JT; Morrison, LT, 1987) |
| "Therapy with vancomycin alone or ciprofloxacin alone did not significantly reduce the number of methicillin-resistant Staphylococcus aureus (MRSA) in bone in rats with experimental osteomyelitis, compared with the number in control rats." | 7.67 | Treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis with ciprofloxacin or vancomycin alone or in combination with rifampin. ( Henry, NK; McConnell, ME; Rouse, MS; Whitesell, AL; Wilson, WR, 1987) |
| "Twenty-seven patients with chronic osteomyelitis were treated with oral ciprofloxacin, 500 mg (13 patients) or 750 mg (13) twice daily and one patient was treated with 300 mg twice daily intravenously." | 7.67 | Treatment of chronic osteomyelitis with ciprofloxacin. ( Davidson, JS; de Graaf, W; de Zwart, DF; Detmar, SJ; Hoogkamp-Korstanje, JA; Rijnks, J; van Bottenburg, HA; van Bruggen, J; Ypma, JF, 1989) |
| "From October 1983 to October 1986, 39 patients with chronic osteomyelitis (of at least two month's duration) were treated with either pefloxacin (n = 15), ofloxacin (n = 17), or ciprofloxacin (n = 7)." | 7.67 | Evaluation of pefloxacin, ofloxacin and ciprofloxacin in the treatment of thirty-nine cases of chronic osteomyelitis. ( Bernard, E; Dellamonica, P; Drugeon, HB; Etesse, H; Garraffo, R, 1989) |
| "Ciprofloxacin, a new carboxyquinoline antimicrobial agent, was compared with tobramycin in the treatment of chronic osteomyelitis due to Pseudomonas aeruginosa in rabbits." | 7.67 | Ciprofloxacin as therapy for experimental osteomyelitis caused by Pseudomonas aeruginosa. ( Norden, CW; Shinners, E, 1985) |
| "Ciprofloxacin displays excellent in vitro activity against gram-negative bacilli and offers the potential for outpatient therapy." | 6.66 | Oral ciprofloxacin therapy for gram-negative bacillary osteomyelitis. ( Francis, JB; Freer, C; Lesse, AJ; Salata, RA; Scheld, WM, 1987) |
| "Osteomyelitis is a major problem worldwide and is devastating due to the potential for limb-threatening sequelae and mortality." | 5.46 | Design, Synthesis, and Antimicrobial Evaluation of a Novel Bone-Targeting Bisphosphonate-Ciprofloxacin Conjugate for the Treatment of Osteomyelitis Biofilms. ( Bakhshalian, N; Bartoszewicz, M; Ebetino, FH; Junka, AF; Lundy, MW; Mahabady, S; McKenna, CE; Neighbors, JD; Oleksy, M; Richard, E; Russell, RG; Sadrerafi, K; Sedghizadeh, PP; Sun, S; Szymczyk, P; Tjokro, N, 2017) |
| "Skull base osteomyelitis is a life-threating condition; clinical suspicion and correct microbiological identification are key to achieve an accurate and timely diagnosis." | 5.46 | Severe skull base osteomyelitis caused by Pseudomonas aeruginosa with successful outcome after prolonged outpatient therapy with continuous infusion of ceftazidime and oral ciprofloxacin: a case report. ( Conde-Díaz, C; Gutiérrez, F; Llenas-García, J; Masiá, M; Parra Grande, M; Terol Esclapez, G, 2017) |
| "Both ciprofloxacin treated groups improved radiographically from week 4 to week 10." | 5.32 | Prevention and treatment of experimental osteomyelitis in dogs with ciprofloxacin-loaded crosslinked high amylose starch implants. ( Chouinard, L; Désévaux, C; Dubreuil, P; Huneault, LM; Lussier, B, 2004) |
| "Ciprofloxacin is a new, oral, broad spectrum fluoroquinolone antibiotic which has a long serum half-life, a low incidence of significant adverse reactions, and is administered twice daily." | 5.28 | Oral ciprofloxacin for osteomyelitis. ( Esterhai, JL; Graziani, AL; MacGregor, RR, 1990) |
| "The osteomyelitis was secondary to trauma in 12 patients, joint replacement in six, previous acute hematogenous infection in two and osteotomy in one." | 5.27 | Treatment of chronic osteomyelitis with ciprofloxacin. ( Mulier, JC; Stuyck, J; Verbist, L, 1987) |
| "Seventy-seven patients [25 with clinical suspicion of diabetic foot osteomyelitis (DFOM), 25 with orthopedic device-related infection (ODRI) and 27 with tubercular bone infection] underwent three-phase Tc-methylenediphosphonate bone scintigraphy followed by static Tc-ciprofloxacin imaging at 1, 4 and 24 h." | 5.13 | Efficacy of indigenously developed single vial kit preparation of 99mTc-ciprofloxacin in the detection of bacterial infection: an Indian experience. ( Aggarwal, S; Bhatnagar, A; Bhattacharya, A; Gill, SS; Goni, VG; Kashyap, R; Mittal, BR; Prasad, V; Rai, R; Sharma, S; Singh, AK; Singh, B; Sunil, HV; Taneja, A, 2008) |
| "The efficacy and safety of three oral fluoroquinolones (lomefloxacin, levofloxacin, and ciprofloxacin) for the treatment of chronic osteomyelitis were analyzed." | 5.09 | Ciprofloxacin, lomefloxacin, or levofloxacin as treatment for chronic osteomyelitis. ( Greenberg, RN; Newman, MT; Pectol, RW; Shariaty, S, 2000) |
| "We undertook a prospective, randomized comparison of oral ciprofloxacin with standard parenteral therapies for the treatment of biopsy-proven osteomyelitis caused by susceptible organisms." | 5.06 | Oral ciprofloxacin compared with parenteral antibiotics in the treatment of osteomyelitis. ( Gentry, LO; Rodriguez, GG, 1990) |
| "8 years) with chronic postsurgical osteomyelitis were treated with ciprofloxacin." | 5.06 | Treatment of chronic postsurgical osteomyelitis with ciprofloxacin. ( Hoogkamp-Korstanje, JA, 1987) |
| "The efficacy and toxicity of ciprofloxacin, an orally administered fluoroquinolone, were evaluated in 24 infections in 23 patients with osteomyelitis caused by aerobic gram-negative bacilli." | 5.06 | Clinical efficacy of ciprofloxacin therapy for gram-negative bacillary osteomyelitis. ( Boscia, J; Bush, LM; Hessen, MT; Ingerman, MJ; Kaufman, DH; Kaye, D; Korzeniowski, OM; Santoro, J; Topiel, M; Weiner, P, 1987) |
| "Twenty adult patients with chronic contiguous osteomyelitis caused by aerobic gram-negative bacilli were enrolled in an open, prospective cooperative study to determine the effect of oral ciprofloxacin therapy in a dosage of 750 mg every 12 hours." | 5.06 | Oral ciprofloxacin therapy for chronic contiguous osteomyelitis caused by aerobic gram-negative bacilli. ( Craven, PC; Gilbert, DN; Marsh, PK; Preheim, LC; Tice, AD, 1987) |
| "Oral ciprofloxacin was used at doses ranging from 500 mg to 1500 mg twice daily for 15 to 476 (mean 139) days for treatment of acute or chronic osteomyelitis in 38 patients, and acute arthritis in two." | 5.06 | Therapy of acute and chronic gram-negative osteomyelitis with ciprofloxacin. Report from a Swedish Study Group. ( , 1988) |
| "The clinical and bacteriological efficacy and safety of ciprofloxacin given as oral doses of 500 to 1,500 mg (normally 750 mg) twice daily for treatment of Gram-negative bacillary osteomyelitis are reviewed." | 4.77 | Ciprofloxacin in the treatment of acute and chronic osteomyelitis: a review. ( Norrby, SR, 1989) |
| " In cystic fibrosis-associated acute exacerbations of chronic pseudomonal pneumonitis, the outcome of oral ciprofloxacin therapy was very satisfactory in the six major studies reported (approximately 85% improvement rates)." | 4.77 | Clinical utility of new quinolones in treatment of osteomyelitis and lower respiratory tract infections. ( Bayer, AS, 1989) |
| " We describe a case of acute-onset peripheral neuropathy associated with ciprofloxacin in a 13-year-old boy who was characterized by severe dysesthesia and erythema of both hands and feet, but which resolved promptly after ceasing the antibiotic." | 4.12 | Ciprofloxacin-associated Peripheral Neuropathy in a Child: A Case Report and Review of the Literature. ( Carvalho de Almeida, C; Grimwood, K; Moloney, S; Morley, C, 2022) |
| "In the present research,we simultaneously addressed the condition of osteomyelitis and osteoporosis by developing a gelatin based chemically cross linked cryogel system embedded with CaCO3 microspheres and ciprofloxacin hydrochloride was incorporated in both the microspheres and the 3D matrix of cryogel." | 3.83 | Dual functioning microspheres embedded crosslinked gelatin cryogels for therapeutic intervention in osteomyelitis and associated bone loss. ( Banala, VT; Mishra, PR; Mittapelly, N; Pandey, G; Pant, A; Sharma, S; Shukla, PK; Singh, P; Trivedi, R, 2016) |
| "The pathogeny of osteomyelitis of the skull base has evolved over time with the emergence of ciprofloxacin-resistant Pseudomonas strains and significant fungal infections, both of which seem to bring a higher morbidity." | 3.80 | Skull base osteomyelitis: incidence of resistance, morbidity, and treatment strategy. ( Duet, M; Guichard, JP; Herman, P; Kania, R; Le Clerc, N; Verillaud, B, 2014) |
| "7), critically ill trauma patient receiving continuous venovenous hemodiafiltration (CVVHDF) was treated with ciprofloxacin 800 mg intravenously every 12 hours for presumed Enterobacter aerogenes (ciprofloxacin minimum inhibitory concentration [MIC] ≤1 μg/mL) lumbar spine osteomyelitis." | 3.76 | High-dose ciprofloxacin for serious gram-negative infection in an obese, critically ill patient receiving continuous venovenous hemodiafiltration. ( Callcut, RA; Healy, DP; Hurford, WE; Mueller, EW; Peterson, JD; Utrup, TR, 2010) |
| "We demonstrate the use of Tc-99m ciprofloxacin imaging in a follow-up case of squamous cell carcinoma of the tongue post hemi-mandibulectomy with clinical suspicion of local recurrence of osteomyelitis." | 3.74 | Diagnosis of mandibular osteomyelitis in probable coexisting tumor recurrence: role of Tc-99m ciprofloxacin imaging. ( Bhatnagar, A; Bhattacharya, A; Gupta, KA; Mittal, BR; Prasad, V; Singh, AK; Singh, B, 2008) |
| "A biodegradable system of poly-D,L-dilactide releasing ciprofloxacin was assessed in a Pseudomonas aeruginosa osteomyelitis model after inoculation of the test pathogen into the left tibia of 76 New Zealand White rabbits; 31 were controls (group A), and 45 were implanted with the polymer at the infection site (group B)." | 3.74 | Local treatment of experimental Pseudomonas aeruginosa osteomyelitis with a biodegradable dilactide polymer releasing ciprofloxacin. ( Andreopoulos, A; Dontas, I; Dounis, E; Giamarellos-Bourboulis, EJ; Giamarellou, H; Kanellakopoulou, K; Karagiannakos, P; Kolia, M; Nakopoulou, L; Thivaios, GC, 2008) |
| "Ciprofloxacin (CFX) implants containing poly(D,L-lactide) and calcium phosphates (tricalcium phosphate and hydroxyapatite) was evaluated in 50 rabbits in an experimental osteomyelitis model." | 3.74 | Efficacy of ciprofloxacin implants in treating experimental osteomyelitis. ( Alvarez, H; Castro, C; Delgado, A; Evora, C; Moujir, L; Perera, A; Sánchez, E; Soriano, I, 2008) |
| "To evaluate use of technetium Tc 99m disodium hydroxymethylene diphosphonate (99m-Tc-HDP) for assessing fracture healing and 99m-Tc-HDP and technetium Tc 99m ciprofloxacin (99m-Tc-CIPRO) for early diagnosis of osteomyelitis in rabbits." | 3.72 | Use of scintigraphy for assessment of fracture healing and early diagnosis of osteomyelitis following fracture repair in rabbits. ( Frisbie, DD; Kawcak, CE; McIlwraith, CW; Southwood, LL; Steyn, PE, 2003) |
| "Retrospective evaluation of Tc-99m ciprofloxacin (infection) scintigraphy consecutively performed in a series of patients clinically suspected for peripheral osteomyelitis (OM), spondylodiscitis (SD) and fever of unknown origin (FUO)." | 3.71 | [Tc-99m ciprofloxacin in clinically selected patients for peripheral osteomyelitis, spondylodiscitis and fever of unknown origin--preliminary results]. ( Gallowitsch, HJ; Gomez, I; Heinisch, M; Kresnik, E; Kumnig, G; Lind, P; Mikosch, P, 2002) |
| " The purpose of this investigation was to develop and characterize a biodegradable, implantable delivery system containing ciprofloxacin hydrochloride (HCl) for the localized treatment of osteomyelitis and to study the extent of drug penetration from the site of implantation into the bone." | 3.70 | In vitro and in vivo release of ciprofloxacin from PLGA 50:50 implants. ( Ramchandani, M; Robinson, D, 1998) |
| "We prepared a composite of fibrin clot and ciprofloxacin for use as a biodegradable antibiotic delivery system with sustained effect for the treatment of chronic osteomyelitis." | 3.69 | Pharmacokinetic study of fibrin clot-ciprofloxacin complex: an in vitro and in vivo experimental investigation. ( Dounis, E; Giamarellou, H; Hatzigrigoris, P; Kanellakopoulou, K; Tsibinos, A; Tsourvakas, S, 1995) |
| "This report describes a relapse of Salmonella paratyphi B infection in a child with biliary atresia, following 2 weeks of treatment with ciprofloxacin." | 3.69 | A relapse of paratyphoid fever after treatment with ciprofloxacin in a child with congenital biliary atresia. ( Eltringham, IJ; Ireland, D; Irish, D; Issler, H; Teall, A; Thalange, N, 1997) |
| "A group of fourteen patients who had chronic osteomyelitis and were treated with oral ciprofloxacin was compared with a group of twelve patients of similar age who had chronic osteomyelitis and received standard parenteral antibiotic therapy consisting of nafcillin, clindamycin, and gentamicin, singly or in combination." | 3.68 | Oral ciprofloxacin compared with standard parenteral antibiotic therapy for chronic osteomyelitis in adults. ( Calhoun, J; Cantrell, JS; Mader, JT, 1990) |
| "The efficacies of the quinolones ciprofloxacin and pefloxacin alone and in combination with rifampin were compared with those of vancomycin alone and in combination with rifampin in a rat model of chronic osteomyelitis caused by methicillin-resistant Staphylococcus aureus." | 3.68 | Comparative efficacies of ciprofloxacin, pefloxacin, and vancomycin in combination with rifampin in a rat model of methicillin-resistant Staphylococcus aureus chronic osteomyelitis. ( Dworkin, R; Kunz, S; Modin, G; Rich, R; Sande, M; Zak, O, 1990) |
| "Seventeen adult patients with chronic osteomyelitis were treated with oral ciprofloxacin, 750 mg twice daily." | 3.68 | Oral ciprofloxacin for treatment of chronic osteomyelitis. ( Bortoletto, ML; Brasil Filho, R; Carvalho, MC; Levi, GC; Lobo, IM; Mendonça, JS; Silva, ML; Trevisanello, C; Yamaguti, A, 1993) |
| "Twenty-two adult patients with osteomyelitis due to Pseudomonas aeruginosa were enrolled in an open, prospective cooperative study to determine the efficacy of oral ciprofloxacin therapy in a dosage of 750 mg twice a day." | 3.68 | Oral ciprofloxacin treatment of Pseudomonas aeruginosa osteomyelitis. ( Dan, M; Pitlik, S; Raz, R; Siegman-Igra, Y, 1990) |
| "After induction of experimental polymicrobic osteomyelitis with Staphylococcus epidermidis and Bacteroides thetaiotaomicron (ciprofloxacin MIC, 0." | 3.68 | Effect of ciprofloxacin on experimental osteomyelitis in the rabbit tibia, induced with a mixed infection of Staphylococcus epidermidis and Bacteroides thetaiotaomicron. ( Gill, LR; Hossler, FE; Lambe, DW; Mayberry-Carson, KJ; Tober-Meyer, B, 1990) |
| "Thirty adult patients with severe skin and soft tissue infections (four with contiguous osteomyelitis) caused by a variety of bacterial pathogens were treated with oral ciprofloxacin." | 3.67 | Treatment of skin and soft tissue infections with oral ciprofloxacin. ( Fass, RJ, 1986) |
| "Ciprofloxacin, a new carboxyquinoline antimicrobial agent, was compared with tobramycin in the treatment of chronic osteomyelitis due to Pseudomonas aeruginosa in rabbits." | 3.67 | Ciprofloxacin as therapy for experimental osteomyelitis caused by Pseudomonas aeruginosa. ( Norden, CW; Shinners, E, 1985) |
| "Ten patients - two with Salmonella septicaemia associated with AIDS; one each Salmonella excretors in the convalescence stage and with Salmonella osteomyelitis; three with abdominal typhoid, and three with Salmonella enteritis - were treated with the gyrase inhibitor ciprofloxacin." | 3.67 | [Ciprofloxacin in Salmonella infection and abdominal typhoid]. ( Hoffmann, HG; Klein, E; Trautmann, M, 1986) |
| "Therapy with vancomycin alone or ciprofloxacin alone did not significantly reduce the number of methicillin-resistant Staphylococcus aureus (MRSA) in bone in rats with experimental osteomyelitis, compared with the number in control rats." | 3.67 | Treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis with ciprofloxacin or vancomycin alone or in combination with rifampin. ( Henry, NK; McConnell, ME; Rouse, MS; Whitesell, AL; Wilson, WR, 1987) |
| "A rabbit model for Staphylococcus aureus osteomyelitis was used to compare the results of treatment with A-56619 and A-56620, two new aryl-fluoroquinolones, and nafcillin." | 3.67 | Comparative evaluation of A-56619, A-56620, and nafcillin in the treatment of experimental Staphylococcus aureus osteomyelitis. ( Adams, KR; Mader, JT; Morrison, LT, 1987) |
| "From October 1983 to October 1986, 39 patients with chronic osteomyelitis (of at least two month's duration) were treated with either pefloxacin (n = 15), ofloxacin (n = 17), or ciprofloxacin (n = 7)." | 3.67 | Evaluation of pefloxacin, ofloxacin and ciprofloxacin in the treatment of thirty-nine cases of chronic osteomyelitis. ( Bernard, E; Dellamonica, P; Drugeon, HB; Etesse, H; Garraffo, R, 1989) |
| "Twenty-seven patients with chronic osteomyelitis were treated with oral ciprofloxacin, 500 mg (13 patients) or 750 mg (13) twice daily and one patient was treated with 300 mg twice daily intravenously." | 3.67 | Treatment of chronic osteomyelitis with ciprofloxacin. ( Davidson, JS; de Graaf, W; de Zwart, DF; Detmar, SJ; Hoogkamp-Korstanje, JA; Rijnks, J; van Bottenburg, HA; van Bruggen, J; Ypma, JF, 1989) |
| "The efficacy and safety of ciprofloxacin in the treatment of Pseudomonas aeruginosa infections was evaluated in 72 patients suffering from upper urinary tract infection (19 patients), deep soft tissue infection (16), chronic osteomyelitis (12), abscess (7), chronic otitis media (6), otitis externa (3) and bronchopneumonia (9)." | 3.67 | Evaluation of ciprofloxacin in the treatment of Pseudomonas aeruginosa infections. ( Daikos, GK; Daphnis, E; Dendrinos, C; Galanakis, N; Giamarellou, H; Stefanou, J, 1986) |
| " In general, the patients received ciprofloxacin at a dosage of 250 to 750 mg every 12 hours; the median dose was 500 mg twice daily." | 2.66 | Ciprofloxacin: an update on clinical experience. ( Arcieri, G; August, R; Becker, N; Griffith, E; Gruenwaldt, G; Heyd, A; O'Brien, B, 1987) |
| " The drug dosage was 300 mg every 12 hours in 19 patients and 200 mg intravenously every 12 hours in nine patients." | 2.66 | Treatment of serious infections with intravenous ciprofloxacin. ( Neu, HC; Scully, BE, 1987) |
| "Ciprofloxacin displays excellent in vitro activity against gram-negative bacilli and offers the potential for outpatient therapy." | 2.66 | Oral ciprofloxacin therapy for gram-negative bacillary osteomyelitis. ( Francis, JB; Freer, C; Lesse, AJ; Salata, RA; Scheld, WM, 1987) |
| "Ciprofloxacin was well tolerated, with the most frequent adverse reactions being rash, gastrointestinal intolerance, and increased levels of liver enzymes, each of which occurred in five patients." | 2.66 | Oral ciprofloxacin in the treatment of serious soft tissue and bone infections. Efficacy, safety, and pharmacokinetics. ( Cumbo, TJ; DeVito, JM; Kuritzky, P; Nix, DE; Schentag, JJ, 1987) |
| "Oral ciprofloxacin was used as the principal antimicrobial agent in the patients described here and therapeutic success was achieved in three of these patients." | 2.39 | Clinical features and antibiotic treatment of septic arthritis and osteomyelitis due to Yersinia enterocolitica. ( Ashford, K; Crowe, M; Ispahani, P, 1996) |
| " Care in selection of patients, attention to optimal duration of therapy and adequate dosage may help to prevent emergence of resistance but combination therapy has not proven effective." | 2.38 | Emergent resistance to ciprofloxacin amongst Pseudomonas aeruginosa and Staphylococcus aureus: clinical significance and therapeutic approaches. ( Ball, P, 1990) |
| "Salmonella osteomyelitis is a well-known complication of hemoglobinopathies but is unusual in healthy individuals." | 1.62 | Chronic Salmonella Osteomyelitis in a Healthy, Immunocompetent Man: A Case Report. ( Habeck, C; Mayer, J; Weiner, S; Willen, J, 2021) |
| "Skull base osteomyelitis is a life-threating condition; clinical suspicion and correct microbiological identification are key to achieve an accurate and timely diagnosis." | 1.46 | Severe skull base osteomyelitis caused by Pseudomonas aeruginosa with successful outcome after prolonged outpatient therapy with continuous infusion of ceftazidime and oral ciprofloxacin: a case report. ( Conde-Díaz, C; Gutiérrez, F; Llenas-García, J; Masiá, M; Parra Grande, M; Terol Esclapez, G, 2017) |
| "Osteomyelitis is a major problem worldwide and is devastating due to the potential for limb-threatening sequelae and mortality." | 1.46 | Design, Synthesis, and Antimicrobial Evaluation of a Novel Bone-Targeting Bisphosphonate-Ciprofloxacin Conjugate for the Treatment of Osteomyelitis Biofilms. ( Bakhshalian, N; Bartoszewicz, M; Ebetino, FH; Junka, AF; Lundy, MW; Mahabady, S; McKenna, CE; Neighbors, JD; Oleksy, M; Richard, E; Russell, RG; Sadrerafi, K; Sedghizadeh, PP; Sun, S; Szymczyk, P; Tjokro, N, 2017) |
| "Endogenous endophthalmitis is a rare condition caused by the hematogenous spread of microorganisms from a remote infection site to the eye." | 1.42 | Endogenous endophthalmitis in a patient with diabetes and foot osteomyelitis. ( de Haller, R; Mavrakanas, TA; Philippe, J, 2015) |
| "A facial palsy was present in 12 patients (60 per cent)." | 1.39 | Skull base osteomyelitis: current microbiology and management. ( Neeff, M; Spielmann, PM; Yu, R, 2013) |
| "Osteomyelitis is an infection located in bone and a notoriously difficult disease to manage, requiring frequent and heavy doses of systemically administered antibiotics." | 1.35 | Linking bisphosphonates to the free amino groups in fluoroquinolones: preparation of osteotropic prodrugs for the prevention of osteomyelitis. ( Arhin, FF; Delorme, D; Dietrich, E; Fadhil, I; Far, AR; Ferreira, SS; Houghton, TJ; Kang, T; Lafontaine, Y; Laquerre, K; Lehoux, D; Liu, J; Moeck, G; Ostiguy, V; Parr, TR; Poirier, H; Sarmiento, I; Tanaka, KS; Viens, F, 2008) |
| "Osteomyelitis is a relatively frequent bacterial infection of the jaw bones." | 1.35 | Mandibular osteomyelitis due to Pseudomonas aeruginosa. Case report. ( Brutto, D; Cappello, V; Carlino, V; Consolo, G; Marescalco, M; Mauro, M; Pappalardo, S; Tanteri, L, 2008) |
| "Osteomyelitis is a difficult to treat bacterial infection of the bone." | 1.35 | Bisphosphonated fluoroquinolone esters as osteotropic prodrugs for the prevention of osteomyelitis. ( Arhin, FF; Caron, L; Delorme, D; Dietrich, E; Fadhil, I; Ferreira, SS; Houghton, TJ; Kang, T; Laquerre, K; Lehoux, D; Liu, J; Moeck, G; Ostiguy, V; Parr, TR; Poirier, H; Rafai Far, A; Sarmiento, I; Tanaka, KS; Viens, F, 2008) |
| "We describe an aggressive progression of septic arthritis and osteomyelitis leading to the complete destruction of the condylar region in a young non-immunosuppressed patient after reconstruction of the ACL." | 1.35 | Devastating femoral osteomyelitis after anterior cruciate ligament reconstruction. ( David, S; Ekkernkamp, A; Frank, M; Matthes, G; Schmucker, U; Seifert, J, 2008) |
| "Progressive cervical kyphosis associated with anterior wedged deformity of the C5 vertebra and posterior C5-C6 spondylolisthesis resulted in compression of the spinal cord and neurological impairment." | 1.34 | Multifocal spinal and extra-spinal Mycobacterium chelonae osteomyelitis in a renal transplant recipient. ( Falagas, ME; Kolia, MD; Korres, DS; Papagelopoulos, PJ; Poulakou, GG; Zahos, KA, 2007) |
| "Ciprofloxacin is a broad-spectrum antibiotic that has been used as a radiolabelled antibiotic in both the diagnosis of infections in rabbits and in clinical trials on humans." | 1.33 | Technetium-99m ciprofloxacin imaging in the diagnosis of postsurgical bony infection and evaluation of the response to antibiotic therapy: A case report. ( Aggarwal, A; Bhattacharya, A; Mittal, BR; Nagi, ON; Singh, AK; Singh, B, 2005) |
| " In an exploratory long-term in vivo study with three rabbits, ciprofloxacin could not be detected from the serum after moderate filling (160 mg) of the tibia (follow-up 168 days), whereas after high dosing (a total dose of 1,000 mg in both tibias) ciprofloxacin was found temporarily at low serum concentrations (14-34 ng/mL) during the follow-up of 300 days." | 1.33 | In vitro and in vivo testing of bioabsorbable antibiotic containing bone filler for osteomyelitis treatment. ( Aro, HT; Jalava, J; Koort, JK; Mäkinen, TJ; Suokas, E; Törmälä, P; Veiranto, M, 2006) |
| "The majority of data evaluating Salmonella infections in sickle cell anemia (SCD) comes from studies performed in children." | 1.33 | Ceftriaxone-resistant Salmonella septicemia and osteomyelitis in sickle cell disease adults. ( Laber, DA; Morgan, JS, 2006) |
| "Osteomyelitis is an extremely unusual complication of invasive otitis externa." | 1.33 | [Temporomandibular osteomyelitis secondary to progressive necrotizing otitis externa]. ( Boulaïch, M; Filali, A; Jamal, H; Kzadri, M; Lazrak, A; Nazih, N; Oujilal, A, 2006) |
| "The diagnosis of typhoid fever was made when blood cultures grew Salmonella typhi." | 1.33 | Multiorgan involvement due to Salmonella typhi: case report. ( Ollé-Goig, JE, 2006) |
| "Both ciprofloxacin treated groups improved radiographically from week 4 to week 10." | 1.32 | Prevention and treatment of experimental osteomyelitis in dogs with ciprofloxacin-loaded crosslinked high amylose starch implants. ( Chouinard, L; Désévaux, C; Dubreuil, P; Huneault, LM; Lussier, B, 2004) |
| "The diagnosis of deep seated bacterial infections, such as intra-abdominal abscesses, endocarditis, and osteomyelitis, can be difficult and delayed, thereby compromising effective treatment." | 1.31 | Imaging bacterial infection with (99m)Tc-ciprofloxacin (Infecton). ( Amaral, H; Bhatnagar, A; Britton, KE; Das, SS; Katamihardja, AH; Malamitsi, J; Moustafa, HM; Padhy, AK; Solanki, KK; Soroa, VE; Sundram, FX; Wareham, DW, 2002) |
| "Vertebral osteomyelitis was diagnosed and treated with antibiotics." | 1.31 | Vertebral osteomyelitis: a rare complication of transvaginal ultrasound-guided oocyte retrieval. ( Almog, B; Amit, A; Azem, F; Bar-Am, A; Rimon, E; Yovel, I, 2000) |
| "IOSP following inguinal hernia repair is extremely rare." | 1.30 | Pseudomonas osteomyelitis of the symphysis pubis after inguinal hernia repair. ( Mader, R; Yeromenco, E, 1999) |
| " Adverse events, premature discontinuation of therapy, and deaths occurred at a similar frequency in both treatment arms." | 1.30 | Safety of long-term therapy with ciprofloxacin: data analysis of controlled clinical trials and review. ( Haverstock, D; Reinhart, H; Segev, S; Yaniv, I, 1999) |
| "A 73-year-old woman with liver cirrhosis who developed H." | 1.30 | Haemophilus aphrophilus bacteraemia complicated with vertebral osteomyelitis and spinal epidural abscess in a patient with liver cirrhosis. ( Chang, SC; Chen, YC; Fang, CT; Hsieh, WC; Hsueh, PR; Hung, CC; Luh, KT, 1997) |
| "Primary sternal osteomyelitis is a rare condition." | 1.29 | Primary sternal osteomyelitis. ( Bassaris, HP; Dougenis, D; Gogos, CA; Skoutelis, AT, 1993) |
| "An unusual case of discitis and vertebral osteomyelitis due to Haemophilus aphrophilus is described." | 1.29 | Haemophilus aphrophilus discitis and vertebral osteomyelitis. ( George, RC; Johnson, AP; Keene, GS; O'Driscoll, JC; Palepou, MF; Weinbren, MJ, 1995) |
| "Treatment with ciprofloxacin resulted in considerable symptomatic improvement: a total of 12 months of treatment is planned." | 1.28 | Salmonella osteomyelitis in aplastic anaemia after antilymphocytic globulin and steroid treatment. ( Allard, S; Laurie, A; O'Driscoll, J, 1992) |
| "The osteomyelitis was secondary to trauma in 12 patients, joint replacement in six, previous acute hematogenous infection in two and osteotomy in one." | 1.27 | Treatment of chronic osteomyelitis with ciprofloxacin. ( Mulier, JC; Stuyck, J; Verbist, L, 1987) |
| "Ciprofloxacin is an effective and safe therapeutic alternative in many tissue infections caused by susceptible microorganisms." | 1.27 | Open, prospective study of the clinical efficacy of ciprofloxacin. ( Bran, JL; Garcia, JF; Mejia, CR; Ramirez, CA, 1985) |
| " Peak serum concentration (Cmax), terminal elimination half-life (t1/2 beta), apparent total body clearance (CL/f), and apparent volume of distribution (Vd/f) of ciprofloxacin were 5." | 1.27 | Pharmacokinetics of ciprofloxacin in acutely ill and convalescent elderly patients. ( Awni, WM; Breitenbucher, R; Guay, DR; Matzke, GR; Obaid, S; Peterson, PK, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 35 (19.66) | 18.7374 |
| 1990's | 39 (21.91) | 18.2507 |
| 2000's | 64 (35.96) | 29.6817 |
| 2010's | 30 (16.85) | 24.3611 |
| 2020's | 10 (5.62) | 2.80 |
| Authors | Studies |
|---|---|
| Tanaka, KS | 2 |
| Houghton, TJ | 2 |
| Kang, T | 2 |
| Dietrich, E | 2 |
| Delorme, D | 2 |
| Ferreira, SS | 2 |
| Caron, L | 1 |
| Viens, F | 2 |
| Arhin, FF | 2 |
| Sarmiento, I | 2 |
| Lehoux, D | 2 |
| Fadhil, I | 2 |
| Laquerre, K | 2 |
| Liu, J | 2 |
| Ostiguy, V | 2 |
| Poirier, H | 2 |
| Moeck, G | 2 |
| Parr, TR | 2 |
| Rafai Far, A | 1 |
| Lafontaine, Y | 1 |
| Far, AR | 1 |
| Sedghizadeh, PP | 2 |
| Sun, S | 2 |
| Junka, AF | 2 |
| Richard, E | 1 |
| Sadrerafi, K | 1 |
| Mahabady, S | 1 |
| Bakhshalian, N | 1 |
| Tjokro, N | 2 |
| Bartoszewicz, M | 2 |
| Oleksy, M | 1 |
| Szymczyk, P | 1 |
| Lundy, MW | 1 |
| Neighbors, JD | 1 |
| Russell, RG | 1 |
| McKenna, CE | 2 |
| Ebetino, FH | 2 |
| Nakatani, N | 1 |
| Miyazaki, R | 1 |
| Nagata, Y | 1 |
| Nozato, T | 1 |
| Ashikaga, T | 1 |
| Kutsuna, S | 1 |
| Morley, C | 1 |
| Carvalho de Almeida, C | 1 |
| Moloney, S | 1 |
| Grimwood, K | 1 |
| Willen, J | 1 |
| Mayer, J | 1 |
| Habeck, C | 1 |
| Weiner, S | 1 |
| Wei, J | 1 |
| Zhou, S | 1 |
| Gu, H | 1 |
| Tong, K | 1 |
| Paleczny, J | 1 |
| Brożyna, M | 1 |
| Dudek-Wicher, R | 1 |
| Dydak, K | 1 |
| Oleksy-Wawrzyniak, M | 1 |
| Madziała, M | 1 |
| Junka, A | 1 |
| Cherian, P | 1 |
| Roshandel, S | 1 |
| Chen, C | 1 |
| Hu, E | 1 |
| Neighbors, J | 1 |
| Pawlak, J | 1 |
| Russell, RGG | 1 |
| Sodagar, E | 1 |
| Memar, MY | 1 |
| Ahangarzadeh Rezaee, M | 1 |
| Barzegar-Jalali, M | 1 |
| Gholikhani, T | 1 |
| Adibkia, K | 1 |
| Ashar, H | 1 |
| Singh, A | 1 |
| Ektate, K | 1 |
| More, S | 1 |
| Ranjan, A | 1 |
| Skwira, A | 1 |
| Szewczyk, A | 1 |
| Barros, J | 1 |
| Laranjeira, M | 1 |
| Monteiro, FJ | 1 |
| Sądej, R | 1 |
| Prokopowicz, M | 1 |
| Malka, S | 1 |
| Goller, M | 1 |
| Dennison-Gibby, S | 1 |
| Puljiz, I | 1 |
| Topic, A | 1 |
| Hanafy, AF | 1 |
| Ali, HSM | 1 |
| El Achy, SN | 1 |
| Habib, EE | 1 |
| Radovanovic, M | 1 |
| Dushenkovska, T | 1 |
| Cvorovic, I | 1 |
| Radovanovic, N | 1 |
| Ramasamy, V | 1 |
| Milosavljevic, K | 1 |
| Surla, J | 1 |
| Jecmenica, M | 1 |
| Radulovic, M | 1 |
| Milovanovic, T | 1 |
| Dumic, I | 1 |
| Park, KH | 1 |
| Kim, DY | 1 |
| Lee, YM | 1 |
| Lee, MS | 1 |
| Kang, KC | 1 |
| Lee, JH | 1 |
| Park, SY | 1 |
| Moon, C | 1 |
| Chong, YP | 1 |
| Kim, SH | 1 |
| Lee, SO | 1 |
| Choi, SH | 1 |
| Kim, YS | 1 |
| Woo, JH | 1 |
| Ryu, BH | 1 |
| Bae, IG | 1 |
| Cho, OH | 1 |
| Honnurappa, V | 1 |
| Ramdass, S | 1 |
| Mahajan, N | 1 |
| Vijayendra, VK | 1 |
| Redleaf, M | 1 |
| Pawar, V | 1 |
| Srivastava, R | 1 |
| Graham, SM | 1 |
| Fishlock, A | 1 |
| Millner, P | 1 |
| Sandoe, J | 1 |
| Whelan-Johnson, S | 1 |
| Isaacs, J | 1 |
| Pullan, RD | 1 |
| Sisto, F | 1 |
| Bonomi, A | 1 |
| Cavicchini, L | 1 |
| Coccè, V | 1 |
| Scaltrito, MM | 1 |
| Bondiolotti, G | 1 |
| Alessandri, G | 1 |
| Parati, E | 1 |
| Pessina, A | 1 |
| Lau, JX | 1 |
| Li, JY | 1 |
| Yong, TY | 1 |
| Le Clerc, N | 1 |
| Verillaud, B | 1 |
| Duet, M | 1 |
| Guichard, JP | 1 |
| Herman, P | 1 |
| Kania, R | 1 |
| Mugnai, G | 1 |
| Pesarini, G | 1 |
| Vassanelli, C | 1 |
| Mavrakanas, TA | 1 |
| de Haller, R | 1 |
| Philippe, J | 1 |
| Krishnan, AG | 1 |
| Jayaram, L | 1 |
| Biswas, R | 1 |
| Nair, M | 1 |
| Orioli, L | 1 |
| Boute, C | 1 |
| Eloy, P | 1 |
| De Wispelaere, JF | 1 |
| De Coene, B | 1 |
| Huang, TD | 1 |
| Ausselet, N | 1 |
| Delaere, B | 1 |
| Dunphy, L | 1 |
| Shetty, P | 1 |
| Kavidasan, A | 1 |
| Rice, A | 1 |
| Pandey, G | 1 |
| Mittapelly, N | 1 |
| Pant, A | 1 |
| Sharma, S | 2 |
| Singh, P | 1 |
| Banala, VT | 1 |
| Trivedi, R | 1 |
| Shukla, PK | 1 |
| Mishra, PR | 1 |
| Mostafa, AA | 1 |
| El-Sayed, MMH | 1 |
| Mahmoud, AA | 1 |
| Gamal-Eldeen, AM | 1 |
| Mutluoglu, M | 1 |
| Lipsky, BA | 1 |
| Conde-Díaz, C | 1 |
| Llenas-García, J | 1 |
| Parra Grande, M | 1 |
| Terol Esclapez, G | 1 |
| Masiá, M | 1 |
| Gutiérrez, F | 1 |
| Pappalardo, S | 1 |
| Tanteri, L | 1 |
| Brutto, D | 1 |
| Marescalco, M | 1 |
| Carlino, V | 1 |
| Consolo, G | 1 |
| Mauro, M | 1 |
| Cappello, V | 1 |
| Singh, B | 4 |
| Prasad, V | 2 |
| Bhattacharya, A | 3 |
| Singh, AK | 4 |
| Bhatnagar, A | 4 |
| Mittal, BR | 4 |
| Gupta, KA | 1 |
| Sunil, HV | 1 |
| Kashyap, R | 3 |
| Taneja, A | 1 |
| Rai, R | 1 |
| Goni, VG | 1 |
| Aggarwal, S | 1 |
| Gill, SS | 1 |
| Barber, AJ | 1 |
| Hanlon, R | 1 |
| Rogers, SN | 1 |
| Ghosh, M | 1 |
| Talwani, R | 1 |
| Gilliam, BL | 1 |
| Mak, JC | 1 |
| Kim, LH | 1 |
| Ong, LT | 1 |
| Bui, TM | 1 |
| Utrup, TR | 1 |
| Mueller, EW | 1 |
| Healy, DP | 1 |
| Callcut, RA | 1 |
| Peterson, JD | 1 |
| Hurford, WE | 1 |
| Harangi, M | 1 |
| Kovács, T | 1 |
| Rákóczi, É | 1 |
| Rejto, L | 1 |
| Mikó, L | 1 |
| Tóth, L | 1 |
| Szucs, G | 1 |
| Galuska, L | 1 |
| Paragh, G | 1 |
| Nayak, AK | 1 |
| Laha, B | 1 |
| Sen, KK | 1 |
| Malamitsi, J | 3 |
| Papadopoulos, A | 1 |
| Vezyrgianni, A | 1 |
| Dalianis, K | 1 |
| Boutsikou, M | 1 |
| Giamarellou, H | 6 |
| Loh, JK | 1 |
| O'Shea, D | 1 |
| O'Connell, K | 1 |
| Crowley, B | 1 |
| Bergin, CJ | 1 |
| Yazdi, HR | 1 |
| Shirazi, MR | 1 |
| Hoseini, MG | 1 |
| Masdari, Z | 1 |
| Ayeni, IV | 1 |
| Calver, G | 1 |
| Spielmann, PM | 1 |
| Yu, R | 1 |
| Neeff, M | 1 |
| Britton, KE | 4 |
| Wareham, DW | 1 |
| Das, SS | 2 |
| Solanki, KK | 2 |
| Amaral, H | 2 |
| Katamihardja, AH | 1 |
| Moustafa, HM | 1 |
| Soroa, VE | 1 |
| Sundram, FX | 2 |
| Padhy, AK | 1 |
| Ma, J | 1 |
| Chan, JK | 1 |
| Bettin, D | 1 |
| Schaphorn, G | 1 |
| Blasius, S | 1 |
| Becker, K | 1 |
| Niemeyer, T | 1 |
| Kanellakopoulou, K | 3 |
| Dounis, E | 3 |
| Grecka, V | 1 |
| Christakopoulos, J | 1 |
| Koratzanis, G | 1 |
| Antoniadou, A | 1 |
| Panoutsopoulos, G | 1 |
| Batsakis, C | 1 |
| Proukakis, C | 1 |
| Wakefield, MC | 1 |
| Kan, VL | 1 |
| Arora, S | 1 |
| Weiswasser, J | 1 |
| Sidawy, AN | 1 |
| Sarda, L | 1 |
| Crémieux, AC | 1 |
| Lebellec, Y | 1 |
| Meulemans, A | 1 |
| Lebtahi, R | 1 |
| Hayem, G | 1 |
| Génin, R | 1 |
| Delahaye, N | 1 |
| Huten, D | 1 |
| Le Guludec, D | 1 |
| Zumiotti, AV | 1 |
| Teng, HW | 1 |
| Ferreira, MC | 1 |
| Southwood, LL | 1 |
| Kawcak, CE | 1 |
| McIlwraith, CW | 1 |
| Frisbie, DD | 1 |
| Steyn, PE | 1 |
| Gupta, SK | 1 |
| Pandit, A | 1 |
| White, DG | 1 |
| Evans, PD | 1 |
| Buxton, TB | 1 |
| Walsh, DS | 1 |
| Harvey, SB | 1 |
| McPherson, JC | 1 |
| Hartmann, JF | 1 |
| Plowman, KM | 1 |
| Huneault, LM | 1 |
| Lussier, B | 1 |
| Dubreuil, P | 1 |
| Chouinard, L | 1 |
| Désévaux, C | 1 |
| Kadry, AA | 1 |
| Al-Suwayeh, SA | 1 |
| Abd-Allah, AR | 1 |
| Bayomi, MA | 1 |
| Koort, JK | 3 |
| Mäkinen, TJ | 4 |
| Suokas, E | 4 |
| Veiranto, M | 5 |
| Jalava, J | 4 |
| Knuuti, J | 1 |
| Törmälä, P | 5 |
| Aro, HT | 4 |
| Aggarwal, A | 1 |
| Nagi, ON | 1 |
| Lankinen, P | 1 |
| Moritz, N | 1 |
| Obradović, V | 1 |
| Artiko, V | 1 |
| Davidović, B | 1 |
| Vucetić, C | 1 |
| Lesić, A | 1 |
| Sudjić, V | 1 |
| Nikolić, N | 1 |
| Marinković, V | 1 |
| Petrović, N | 1 |
| Bosnjaković, V | 1 |
| Orhan, Z | 1 |
| Cevher, E | 1 |
| Mülazimoglu, L | 1 |
| Gürcan, D | 1 |
| Alper, M | 1 |
| Araman, A | 1 |
| Ozsoy, Y | 1 |
| Djalilian, HR | 1 |
| Shamloo, B | 1 |
| Thakkar, KH | 1 |
| Najme-Rahim, M | 1 |
| Wilson, G | 1 |
| Prabhu, N | 1 |
| Easow, JM | 1 |
| Mukhopadhyay, C | 1 |
| Morgan, JS | 1 |
| Laber, DA | 1 |
| Nazih, N | 1 |
| Filali, A | 1 |
| Boulaïch, M | 1 |
| Jamal, H | 1 |
| Oujilal, A | 1 |
| Lazrak, A | 1 |
| Kzadri, M | 1 |
| García-Alvarez, F | 2 |
| Monzón, M | 2 |
| Grasa, JM | 1 |
| Laclériga, A | 2 |
| Amorena, B | 2 |
| García-Alvarez, I | 1 |
| Navarro-Zorraquino, M | 1 |
| Alvarez, FG | 1 |
| Dutta, P | 1 |
| Bhansali, A | 1 |
| Masoodi, SR | 1 |
| Chang, CM | 1 |
| Lee, HC | 1 |
| Lee, NY | 1 |
| Huang, GC | 1 |
| Lee, IW | 1 |
| Ko, WC | 1 |
| Patel, SM | 1 |
| Saravolatz, LD | 1 |
| Altay, M | 1 |
| Kanbay, M | 1 |
| Kurultak, I | 1 |
| Altay, FA | 1 |
| Aydogan, T | 1 |
| Akcay, A | 1 |
| Duranay, M | 1 |
| Korres, DS | 1 |
| Papagelopoulos, PJ | 1 |
| Zahos, KA | 1 |
| Kolia, MD | 1 |
| Poulakou, GG | 1 |
| Falagas, ME | 1 |
| Sharma, R | 2 |
| Tewari, KN | 1 |
| Mondal, A | 2 |
| Mishra, AK | 1 |
| Chopra, MK | 2 |
| Rawat, H | 1 |
| Tripathi, RP | 1 |
| Ollé-Goig, JE | 1 |
| Alvarez, H | 1 |
| Castro, C | 1 |
| Moujir, L | 1 |
| Perera, A | 1 |
| Delgado, A | 1 |
| Soriano, I | 1 |
| Evora, C | 1 |
| Sánchez, E | 1 |
| Lee, CH | 1 |
| Lin, WC | 1 |
| Chia, JH | 1 |
| Su, LH | 1 |
| Chien, CC | 1 |
| Mao, AH | 1 |
| Liu, JW | 1 |
| Sundararaj, GD | 1 |
| Babu, N | 1 |
| Amritanand, R | 1 |
| Venkatesh, K | 1 |
| Nithyananth, M | 1 |
| Cherian, VM | 1 |
| Lee, VN | 1 |
| Frank, M | 1 |
| Schmucker, U | 1 |
| David, S | 1 |
| Matthes, G | 1 |
| Ekkernkamp, A | 1 |
| Seifert, J | 1 |
| Otter, JA | 1 |
| Klein, JL | 1 |
| Watts, TL | 1 |
| Kearns, AM | 1 |
| French, GL | 1 |
| Putcharoen, O | 1 |
| Suankratay, C | 1 |
| Scognamiglio, F | 1 |
| Corso, C | 1 |
| Madeo, D | 1 |
| Castaman, G | 1 |
| Visco, C | 1 |
| Borghero, C | 1 |
| Ruggeri, M | 1 |
| Rodeghiero, F | 1 |
| Tekaya, R | 1 |
| Saidane, O | 1 |
| Abdelmoula, L | 1 |
| Ben Hadj Yahia, C | 1 |
| Manamani, L | 1 |
| Chaabouni, L | 1 |
| Zouari, R | 1 |
| Thivaios, GC | 1 |
| Kolia, M | 1 |
| Dontas, I | 1 |
| Nakopoulou, L | 1 |
| Giamarellos-Bourboulis, EJ | 1 |
| Andreopoulos, A | 1 |
| Karagiannakos, P | 1 |
| Tsourvakas, S | 1 |
| Hatzigrigoris, P | 1 |
| Tsibinos, A | 1 |
| Azizi, SA | 1 |
| Fayad, PB | 1 |
| Fulbright, R | 1 |
| Giroux, ML | 1 |
| Waxman, SG | 1 |
| MacKay, AD | 1 |
| Mehta, A | 1 |
| Skoutelis, AT | 1 |
| Dougenis, D | 1 |
| Gogos, CA | 1 |
| Bassaris, HP | 1 |
| de Miguel, J | 1 |
| Collazos, J | 1 |
| Ayarza, R | 1 |
| Abaitua, JM | 1 |
| Quilez, J | 1 |
| Hasan, S | 1 |
| Hall, FC | 1 |
| Maidment, G | 1 |
| Moshfeghi, M | 1 |
| Mandler, HD | 1 |
| Yamaguti, A | 1 |
| Trevisanello, C | 1 |
| Lobo, IM | 1 |
| Carvalho, MC | 1 |
| Bortoletto, ML | 1 |
| Silva, ML | 1 |
| Brasil Filho, R | 1 |
| Levi, GC | 1 |
| Mendonça, JS | 1 |
| Peterson, MC | 1 |
| Farr, RW | 1 |
| Castiglia, M | 1 |
| Goodhart, GL | 1 |
| O'Driscoll, JC | 1 |
| Keene, GS | 1 |
| Weinbren, MJ | 1 |
| Johnson, AP | 1 |
| Palepou, MF | 1 |
| George, RC | 1 |
| Kamarulzaman, A | 1 |
| Briggs, RJ | 1 |
| Fabinyi, G | 1 |
| Richards, MJ | 1 |
| Crowe, M | 1 |
| Ashford, K | 1 |
| Ispahani, P | 1 |
| Workman, MR | 1 |
| Philpott-Howard, J | 1 |
| Bragman, S | 1 |
| Brito-Babapulle, F | 1 |
| Bellingham, AJ | 1 |
| Tsui, HF | 1 |
| Chiu, KH | 1 |
| Leung, KS | 1 |
| Eltringham, IJ | 1 |
| Thalange, N | 1 |
| Irish, D | 1 |
| Issler, H | 1 |
| Teall, A | 1 |
| Ireland, D | 1 |
| Rissing, JP | 1 |
| Hung, CC | 1 |
| Hsueh, PR | 1 |
| Chen, YC | 1 |
| Fang, CT | 1 |
| Chang, SC | 1 |
| Luh, KT | 1 |
| Hsieh, WC | 1 |
| Ramchandani, M | 1 |
| Robinson, D | 1 |
| Segev, S | 1 |
| Yaniv, I | 1 |
| Haverstock, D | 1 |
| Reinhart, H | 1 |
| Mader, R | 1 |
| Yeromenco, E | 1 |
| Donati, L | 1 |
| Quadri, P | 1 |
| Reiner, M | 1 |
| Morales, B | 1 |
| Pruzzo, R | 1 |
| Greenberg, RN | 3 |
| Newman, MT | 1 |
| Shariaty, S | 1 |
| Pectol, RW | 1 |
| Javaloyas de Morlius, M | 1 |
| Monreal Portella, M | 1 |
| Jayaraman, S | 1 |
| Al-Nahhas, AM | 1 |
| Vivian, G | 1 |
| Gilbert, TJ | 1 |
| Hughes, PM | 1 |
| Tejan-Sie, SA | 1 |
| Avery, RK | 1 |
| Mossad, SB | 1 |
| Almog, B | 1 |
| Rimon, E | 1 |
| Yovel, I | 1 |
| Bar-Am, A | 1 |
| Amit, A | 1 |
| Azem, F | 1 |
| Gupta, V | 1 |
| Poddar, B | 1 |
| Kumar Gupta, R | 1 |
| Issaivanan, M | 1 |
| Basu, S | 1 |
| Yadav, A | 1 |
| Joshi, RM | 1 |
| Sengupta, S | 1 |
| Jagadishchandra, K | 1 |
| Murty, R | 1 |
| Shivananda, PG | 1 |
| de Lalla, F | 1 |
| Pellizzer, G | 1 |
| Strazzabosco, M | 1 |
| Martini, Z | 1 |
| Du Jardin, G | 1 |
| Lora, L | 1 |
| Fabris, P | 1 |
| Benedetti, P | 1 |
| Erle, G | 1 |
| Wong, WY | 1 |
| Ang, ES | 1 |
| Goh, AS | 1 |
| Ng, DC | 1 |
| Yu, S | 1 |
| Sonmezoglu, K | 1 |
| Sonmezoglu, M | 1 |
| Halac, M | 1 |
| Akgün, I | 1 |
| Türkmen, C | 1 |
| Onsel, C | 1 |
| Kanmaz, B | 1 |
| Solanki, K | 1 |
| Uslu, I | 1 |
| Yapar, Z | 1 |
| Kibar, M | 1 |
| Yapar, AF | 1 |
| Toğrul, E | 1 |
| Kayaselçuk, U | 1 |
| Sarpel, Y | 1 |
| Gracia, E | 1 |
| Leiva, J | 1 |
| Oteiza, C | 1 |
| Rawat, HS | 1 |
| Dumarey, N | 1 |
| Blocklet, D | 1 |
| Appelboom, T | 1 |
| Tant, L | 1 |
| Schoutens, A | 1 |
| Gallowitsch, HJ | 1 |
| Heinisch, M | 1 |
| Mikosch, P | 1 |
| Kresnik, E | 1 |
| Kumnig, G | 1 |
| Gomez, I | 1 |
| Lind, P | 1 |
| Banky, JP | 1 |
| Ostergaard, L | 1 |
| Spelman, D | 1 |
| Leinonen, S | 1 |
| Waris, T | 1 |
| Ashammakhi, N | 1 |
| Allard, S | 1 |
| O'Driscoll, J | 1 |
| Laurie, A | 1 |
| Marín Díez, JF | 1 |
| Botella Romero, F | 1 |
| Rojas Hidalgo, E | 1 |
| Levenson, MJ | 1 |
| Parisier, SC | 1 |
| Dolitsky, J | 1 |
| Bindra, G | 1 |
| Blumberg, HM | 1 |
| Dronda, F | 1 |
| Villodres, J | 1 |
| Ball, P | 1 |
| García-Rosario, LN | 1 |
| Ramírez-Ronda, CH | 1 |
| Gentry, LO | 1 |
| Rodriguez, GG | 1 |
| Mumford, CJ | 1 |
| Ginsberg, L | 1 |
| Mayberry-Carson, KJ | 1 |
| Tober-Meyer, B | 1 |
| Gill, LR | 1 |
| Lambe, DW | 1 |
| Hossler, FE | 1 |
| Kennedy, CA | 1 |
| Goetz, MB | 1 |
| Mathisen, GE | 1 |
| Mader, JT | 2 |
| Cantrell, JS | 1 |
| Calhoun, J | 1 |
| MacGregor, RR | 1 |
| Graziani, AL | 1 |
| Esterhai, JL | 1 |
| Dan, M | 1 |
| Siegman-Igra, Y | 1 |
| Pitlik, S | 1 |
| Raz, R | 1 |
| Dworkin, R | 1 |
| Modin, G | 1 |
| Kunz, S | 1 |
| Rich, R | 1 |
| Zak, O | 1 |
| Sande, M | 1 |
| Roca, R | 1 |
| Segura, A | 1 |
| Pahissa, A | 1 |
| González, J | 1 |
| Dellamonica, P | 1 |
| Bernard, E | 1 |
| Etesse, H | 1 |
| Garraffo, R | 1 |
| Drugeon, HB | 1 |
| Gudiol, F | 1 |
| Cabellos, C | 1 |
| Pallares, R | 1 |
| Linares, J | 1 |
| Ariza, J | 1 |
| Fong, IW | 1 |
| Norrby, SR | 1 |
| Modai, J | 1 |
| Bayer, AS | 1 |
| Hoogkamp-Korstanje, JA | 2 |
| van Bottenburg, HA | 1 |
| van Bruggen, J | 1 |
| Davidson, JS | 1 |
| Detmar, SJ | 1 |
| de Graaf, W | 1 |
| Rijnks, J | 1 |
| Ypma, JF | 1 |
| de Zwart, DF | 1 |
| Scully, BE | 2 |
| Neu, HC | 4 |
| Parry, MF | 1 |
| Mandell, W | 1 |
| Ramirez, CA | 1 |
| Bran, JL | 1 |
| Mejia, CR | 1 |
| Garcia, JF | 1 |
| Daphnis, E | 2 |
| Dendrinos, C | 2 |
| Daikos, GK | 2 |
| Galanakis, N | 1 |
| Stefanou, J | 1 |
| Dürig, M | 1 |
| Braun, R | 1 |
| Linder, P | 1 |
| Gattlen, W | 1 |
| Harder, F | 1 |
| Hoen, MM | 1 |
| Downs, RH | 1 |
| LaBounty, GL | 1 |
| Nespeca, JA | 1 |
| Norden, CW | 1 |
| Shinners, E | 1 |
| Westblom, TU | 1 |
| Abele, B | 1 |
| Blount, R | 1 |
| Hyslop, DL | 1 |
| Stuyck, J | 1 |
| Verbist, L | 1 |
| Mulier, JC | 1 |
| Nix, DE | 1 |
| Cumbo, TJ | 1 |
| Kuritzky, P | 1 |
| DeVito, JM | 1 |
| Schentag, JJ | 1 |
| Lesse, AJ | 1 |
| Freer, C | 1 |
| Salata, RA | 1 |
| Francis, JB | 1 |
| Scheld, WM | 1 |
| Gilbert, DN | 1 |
| Tice, AD | 2 |
| Marsh, PK | 2 |
| Craven, PC | 2 |
| Preheim, LC | 1 |
| Hessen, MT | 1 |
| Ingerman, MJ | 1 |
| Kaufman, DH | 1 |
| Weiner, P | 1 |
| Santoro, J | 1 |
| Korzeniowski, OM | 1 |
| Boscia, J | 1 |
| Topiel, M | 1 |
| Bush, LM | 1 |
| Kaye, D | 1 |
| Reilly, PM | 2 |
| Bollinger, M | 1 |
| Weinandt, WJ | 2 |
| Arcieri, G | 1 |
| Griffith, E | 1 |
| Gruenwaldt, G | 1 |
| Heyd, A | 1 |
| O'Brien, B | 1 |
| Becker, N | 1 |
| August, R | 1 |
| Kennedy, DJ | 1 |
| Luppen, KL | 1 |
| Bollinger, MR | 1 |
| Aguirre, F | 1 |
| Kodesch, F | 1 |
| Saeed, AM | 1 |
| Morrison, LT | 1 |
| Adams, KR | 1 |
| Guay, DR | 1 |
| Awni, WM | 1 |
| Peterson, PK | 1 |
| Obaid, S | 1 |
| Breitenbucher, R | 1 |
| Matzke, GR | 1 |
| Henry, NK | 1 |
| Rouse, MS | 1 |
| Whitesell, AL | 1 |
| McConnell, ME | 1 |
| Wilson, WR | 1 |
| Klein, E | 1 |
| Trautmann, M | 1 |
| Hoffmann, HG | 1 |
| Fass, RJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A National, Prospective, Randomized, Multicenter, Controlled Head-to-Head Comparison of Bioactive Glass and Beta-Tricalcium Phosphate as Bone Graft Substitute in Filling of Contained Bone Defects[NCT00841152] | 120 participants (Actual) | Observational | 2009-03-31 | Completed | |||
| Bioactive Glass Granules as Bone Graft Substitute in Filling Material of Bone Defects[NCT01304121] | Phase 4 | 48 participants (Actual) | Interventional | 2006-10-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
12 reviews available for ciprofloxacin and Osteomyelitis
| Article | Year |
|---|---|
Idiosyncratic Drug-Induced Liver Injury Due to Ciprofloxacin: A Report of Two Cases and Review of the Literature.
Topics: Adult; Aged, 80 and over; Anti-Bacterial Agents; Chemical and Drug Induced Liver Injury; Ciprofloxac | 2018 |
Nonoperative management of diabetic foot infections.
Topics: Anti-Infective Agents; Bacterial Infections; Cellulitis; Ciprofloxacin; Diabetic Foot; Humans; Osteo | 2003 |
Monotherapy versus combination therapy.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; Cellulit | 2006 |
Community-acquired osteomyelitis caused by Chryseobacterium meningosepticum: case report and literature review.
Topics: Aged; Anti-Bacterial Agents; Chryseobacterium; Ciprofloxacin; Community-Acquired Infections; Female; | 2008 |
Skull osteomyelitis due to Salmonella species: two case reports and review.
Topics: Adolescent; Adult; Anti-Infective Agents; Cefotaxime; Cephalosporins; Child; Ciprofloxacin; Female; | 1996 |
Clinical features and antibiotic treatment of septic arthritis and osteomyelitis due to Yersinia enterocolitica.
Topics: Administration, Oral; Adolescent; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Age | 1996 |
Antimicrobial therapy for chronic osteomyelitis in adults: role of the quinolones.
Topics: Adult; Anti-Infective Agents; Chronic Disease; Ciprofloxacin; Humans; Osteomyelitis; Randomized Cont | 1997 |
Chronic relapsing salmonella osteomyelitis in an immunocompetent patient: case report and literature review.
Topics: Adult; Anti-Infective Agents; Cefazolin; Ceftriaxone; Cephalosporins; Chronic Disease; Ciprofloxacin | 2002 |
Emergent resistance to ciprofloxacin amongst Pseudomonas aeruginosa and Staphylococcus aureus: clinical significance and therapeutic approaches.
Topics: Ciprofloxacin; Cystic Fibrosis; Drug Resistance, Microbial; Humans; Osteomyelitis; Pseudomonas aerug | 1990 |
[The use of ciprofloxacin in patients with osteomyelitis associated with vascular insufficiency].
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Humans; Leg; Osteomyelitis; Vascul | 1990 |
Ciprofloxacin in the treatment of acute and chronic osteomyelitis: a review.
Topics: Bacterial Infections; Ciprofloxacin; Drug Evaluation; Gram-Negative Bacteria; Humans; Osteomyelitis; | 1989 |
Clinical utility of new quinolones in treatment of osteomyelitis and lower respiratory tract infections.
Topics: Animals; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Cross Infection; Cystic Fibrosi | 1989 |
21 trials available for ciprofloxacin and Osteomyelitis
| Article | Year |
|---|---|
Efficacy of indigenously developed single vial kit preparation of 99mTc-ciprofloxacin in the detection of bacterial infection: an Indian experience.
Topics: Adolescent; Adult; Bacterial Infections; Bone Diseases, Infectious; Ciprofloxacin; Diabetic Foot; Di | 2008 |
Infecton: a 99mTc-ciprofloxacin radiopharmaceutical for the detection of bone infection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Ciprofloxacin; Citrates; Diphosphonates; Female; | 2003 |
Inability of 99mTc-ciprofloxacin scintigraphy to discriminate between septic and sterile osteoarticular diseases.
Topics: Adult; Aged; Arthritis, Infectious; Bone Diseases; Ciprofloxacin; Diagnosis, Differential; False Pos | 2003 |
Cold-hot mismatch between Tc-99m HMPAO-labeled leukocytes and Tc-99m ciprofloxacin in axial skeleton infections: a report of three cases.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Female; Humans; Leukocytes; Male; Middle Aged; Osteomye | 1999 |
Ciprofloxacin, lomefloxacin, or levofloxacin as treatment for chronic osteomyelitis.
Topics: Adult; Anti-Infective Agents; Chronic Disease; Ciprofloxacin; Female; Fluoroquinolones; Follow-Up St | 2000 |
Randomized prospective controlled trial of recombinant granulocyte colony-stimulating factor as adjunctive therapy for limb-threatening diabetic foot infection.
Topics: Adjuvants, Immunologic; Adult; Aged; Amputation, Surgical; Anti-Bacterial Agents; Anti-Infective Age | 2001 |
Evaluation of technetium-99m ciprofloxacin (Infecton) in the imaging of infection.
Topics: Abscess; Adult; Aged; Bacterial Infections; Ciprofloxacin; Evaluation Studies as Topic; Female; Huma | 2000 |
The efficacy of technetium-99m ciprofloxacin (Infecton) imaging in suspected orthopaedic infection: a comparison with sequential bone/gallium imaging.
Topics: Arthritis, Infectious; Bone and Bones; Ciprofloxacin; Female; Femur; Gallium Radioisotopes; Hip Join | 2001 |
Infecton is not specific for bacterial osteo-articular infective pathology.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arthritis, Infectious; Child; Child, Preschool; Ciproflo | 2002 |
Oral ciprofloxacin compared with parenteral antibiotics in the treatment of osteomyelitis.
Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Chronic Disease; Ciprofloxacin; Fema | 1990 |
The role of fluoroquinolones in the management of skin, soft tissue, and bone infections.
Topics: Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Clinical Trials as Topic; Dermatitis; En | 1989 |
Treatment of serious infections with intravenous ciprofloxacin. French Multicenter Study Group.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteria; Bacterial Infections; Ciprofloxacin; Female; H | 1989 |
Therapy of acute and chronic gram-negative osteomyelitis with ciprofloxacin. Report from a Swedish Study Group.
Topics: Acute Disease; Administration, Oral; Arthritis; Bacterial Infections; Chronic Disease; Ciprofloxacin | 1988 |
Treatment of chronic postsurgical osteomyelitis with ciprofloxacin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Chronic Disease; Ciprofloxacin; Cl | 1987 |
Oral ciprofloxacin in the treatment of serious soft tissue and bone infections. Efficacy, safety, and pharmacokinetics.
Topics: Administration, Oral; Aged; Bacterial Infections; Ciprofloxacin; Clinical Trials as Topic; Diabetes | 1987 |
Oral ciprofloxacin therapy for gram-negative bacillary osteomyelitis.
Topics: Bacterial Infections; Ciprofloxacin; Clinical Trials as Topic; Drug Tolerance; Female; Gram-Negative | 1987 |
Oral ciprofloxacin therapy for chronic contiguous osteomyelitis caused by aerobic gram-negative bacilli.
Topics: Adult; Aged; Bacterial Infections; Ciprofloxacin; Clinical Trials as Topic; Digestive System; Female | 1987 |
Clinical efficacy of ciprofloxacin therapy for gram-negative bacillary osteomyelitis.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Bacterial Infections; Ciprofloxacin; Clinical | 1987 |
Randomized trial of ciprofloxacin compared with other antimicrobial therapy in the treatment of osteomyelitis.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Ciprofloxacin; Clini | 1987 |
Treatment of serious infections with intravenous ciprofloxacin.
Topics: Administration, Oral; Adult; Aged; Arthritis, Infectious; Bacterial Infections; Ciprofloxacin; Clini | 1987 |
Ciprofloxacin: an update on clinical experience.
Topics: Bacterial Infections; Ciprofloxacin; Clinical Trials as Topic; Digestive System; Drug Resistance, Mi | 1987 |
145 other studies available for ciprofloxacin and Osteomyelitis
| Article | Year |
|---|---|
Bisphosphonated fluoroquinolone esters as osteotropic prodrugs for the prevention of osteomyelitis.
Topics: Animals; Disease Models, Animal; Esters; Female; Fluoroquinolones; Humans; Molecular Structure; Orga | 2008 |
Linking bisphosphonates to the free amino groups in fluoroquinolones: preparation of osteotropic prodrugs for the prevention of osteomyelitis.
Topics: Amines; Animals; Cell Line; Diphosphonates; Female; Fluoroquinolones; Molecular Structure; Osteomyel | 2008 |
Design, Synthesis, and Antimicrobial Evaluation of a Novel Bone-Targeting Bisphosphonate-Ciprofloxacin Conjugate for the Treatment of Osteomyelitis Biofilms.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Biofilms; Bone and Bones; Ciprofloxa | 2017 |
Cervical Spine Osteomyelitis Caused by Campylobacter jejuni Without Gastrointestinal Symptoms.
Topics: Anti-Bacterial Agents; Campylobacter jejuni; Cervical Vertebrae; Ciprofloxacin; Humans; Magnetic Res | 2022 |
Ciprofloxacin-associated Peripheral Neuropathy in a Child: A Case Report and Review of the Literature.
Topics: Adolescent; Anti-Bacterial Agents; Ciprofloxacin; Erythema; Foot; Hand; Humans; Male; Osteomyelitis; | 2022 |
Chronic Salmonella Osteomyelitis in a Healthy, Immunocompetent Man: A Case Report.
Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; Humans; Male; Osteomyelitis; Salmonella; Salmonella Inf | 2021 |
Meropenem-loaded Cement Is Effective in Preventing Gram-negative Osteomyelitis in an Animal Model.
Topics: Animals; Anti-Bacterial Agents; Aztreonam; Bone Cements; Ceftazidime; Ciprofloxacin; Escherichia col | 2023 |
The Medium Composition Impacts
Topics: Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Gentamicins; Humans; Levofloxacin; Microbial Sensiti | 2022 |
Real-Time Impedance-Based Monitoring of the Growth and Inhibition of Osteomyelitis Biofilm Pathogen
Topics: Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Diphosphonates; Durapatite; Electric Impedance; Etid | 2023 |
The Antibacterial Effect of Ciprofloxacin Loaded Calcium Carbonate (CaCO
Topics: Anti-Bacterial Agents; Calcium Carbonate; Ciprofloxacin; Humans; Microbial Sensitivity Tests; Nanopa | 2023 |
Treating methicillin-resistant
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Liposomes; Methicillin-Resistant Staphylococcus aureu | 2023 |
Biocompatible antibiotic-loaded mesoporous silica/bioglass/collagen-based scaffolds as bone drug delivery systems.
Topics: Animals; Anti-Bacterial Agents; Biocompatible Materials; Bone and Bones; Bone Regeneration; Chick Em | 2023 |
Septic Arthritis and Osteomyelitis Caused by
Topics: Animals; Anseriformes; Anti-Bacterial Agents; Arthritis, Infectious; Bird Diseases; Charadriiformes; | 2020 |
Campylobacter jejuni vertebral osteomyelitis.
Topics: Anti-Bacterial Agents; Campylobacter Infections; Campylobacter jejuni; Ciprofloxacin; Humans; Male; | 2017 |
Dual effect biodegradable ciprofloxacin loaded implantable matrices for osteomyelitis: controlled release and osteointegration.
Topics: Animals; Anti-Bacterial Agents; Calorimetry, Differential Scanning; Ciprofloxacin; Delayed-Action Pr | 2018 |
Selection of an appropriate empiric antibiotic regimen in hematogenous vertebral osteomyelitis.
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; be | 2019 |
Effective Inexpensive Management of Necrotizing Otitis Externa Is Possible in Resource-Poor Settings.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Earache; Female; Humans; India; Male; Meropenem; Middle Aged; | 2019 |
Chitosan-polycaprolactone blend sponges for management of chronic osteomyelitis: A preliminary characterization and in vitro evaluation.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Biocompatible Materials; Ce | 2019 |
The management gram-negative bacterial haematogenous vertebral osteomyelitis: a case series of diagnosis, treatment and therapeutic outcomes.
Topics: Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ciprofloxacin; Cohort Studies; Comorbid | 2013 |
Sacro-iliac osteomyelitis in a 13 year old boy following perforated appendicitis.
Topics: Adolescent; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Appendectomy; Appe | 2013 |
Human mesenchymal stromal cells can uptake and release ciprofloxacin, acquiring in vitro anti-bacterial activity.
Topics: Anti-Bacterial Agents; Blood Bactericidal Activity; Bone and Bones; Cell- and Tissue-Based Therapy; | 2014 |
Non-contiguous multifocal vertebral osteomyelitis caused by Serratia marcescens.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Humans; Male; Meropenem; Middle Aged; Osteomyelitis; Serratia | 2015 |
Skull base osteomyelitis: incidence of resistance, morbidity, and treatment strategy.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Fe | 2014 |
Osteomyelitis of the clavicle following to a pacemaker implantation.
Topics: Anti-Bacterial Agents; Cardiac Pacing, Artificial; Cefepime; Cephalosporins; Ciprofloxacin; Clavicle | 2014 |
Endogenous endophthalmitis in a patient with diabetes and foot osteomyelitis.
Topics: Aged; Anti-Bacterial Agents; Ciprofloxacin; Diabetes Complications; Diabetes Mellitus; Endophthalmit | 2015 |
Evaluation of antibacterial activity and cytocompatibility of ciprofloxacin loaded gelatin-hydroxyapatite scaffolds as a local drug delivery system for osteomyelitis treatment.
Topics: Adipose Tissue; Anti-Bacterial Agents; Bacterial Adhesion; Cells, Cultured; Ciprofloxacin; Drug Deli | 2015 |
Central skull base osteomyelitis: a rare but life-threatening disease.
Topics: Aged; Anti-Bacterial Agents; Ciprofloxacin; Delayed Diagnosis; Earache; Humans; Magnetic Resonance I | 2015 |
Unusual cause of chest pain: empyema necessitans and tubercular osteomyelitis of the rib in an immunocompetent man.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Antibiotics, Antitubercular; Chest Pain; Ciprofloxacin; Dr | 2016 |
Dual functioning microspheres embedded crosslinked gelatin cryogels for therapeutic intervention in osteomyelitis and associated bone loss.
Topics: Alkaline Phosphatase; Animals; Anti-Bacterial Agents; Calcium Carbonate; Cell Survival; Cells, Cultu | 2016 |
Bioactive/Natural Polymeric Scaffolds Loaded with Ciprofloxacin for Treatment of Osteomyelitis.
Topics: Anti-Bacterial Agents; Biocompatible Materials; Bone and Bones; Cell Proliferation; Ceramics; Chitos | 2017 |
Non-surgical treatment of diabetic foot osteomyelitis.
Topics: Aged; Anti-Bacterial Agents; Ciprofloxacin; Diabetes Mellitus, Type 2; Diabetic Foot; Humans; Male; | 2017 |
Severe skull base osteomyelitis caused by Pseudomonas aeruginosa with successful outcome after prolonged outpatient therapy with continuous infusion of ceftazidime and oral ciprofloxacin: a case report.
Topics: Aged; Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Diagnostic Errors; Drug Therapy, Combinatio | 2017 |
Mandibular osteomyelitis due to Pseudomonas aeruginosa. Case report.
Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; Combined Modality Therapy; Debridement; Drug Resistance | 2008 |
Diagnosis of mandibular osteomyelitis in probable coexisting tumor recurrence: role of Tc-99m ciprofloxacin imaging.
Topics: Ciprofloxacin; Humans; Male; Mandibular Diseases; Middle Aged; Neoplasm Recurrence, Local; Organotec | 2008 |
Skull base osteomyelitis after maxillectomy: a rare complication.
Topics: Ameloblastoma; Ciprofloxacin; Eustachian Tube; Humans; Magnetic Resonance Imaging; Male; Maxillary N | 2009 |
Propionibacterium skull osteomyelitis treated with daptomycin.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Daptomycin; Gram-Positive Bacterial Infections; Humans; Male; | 2009 |
Acute abducens nerve palsy and weight loss due to skull base osteomyelitis.
Topics: Abducens Nerve Diseases; Aged, 80 and over; Anti-Bacterial Agents; Ciprofloxacin; Humans; Magnetic R | 2010 |
High-dose ciprofloxacin for serious gram-negative infection in an obese, critically ill patient receiving continuous venovenous hemodiafiltration.
Topics: Anti-Infective Agents; Ciprofloxacin; Critical Illness; Enterobacter aerogenes; Enterobacteriaceae I | 2010 |
Malignancy or inflammation? A case report of a young man with fever of unknown origin.
Topics: Adult; Anti-Infective Agents; Chronic Disease; Ciprofloxacin; Fever of Unknown Origin; Humans; Male; | 2011 |
Development of hydroxyapatite-ciprofloxacin bone-implants using "Quality by design".
Topics: Anti-Bacterial Agents; Biocompatible Materials; Chemical Precipitation; Ciprofloxacin; Delayed-Actio | 2011 |
The value of successive Infecton scans in assessing the presence of chronic bone and joint infection and in predicting its evolution after treatment and after a prolonged follow-up.
Topics: Adult; Aged; Arthrography; Blood Sedimentation; Bone and Bones; Bone Diseases, Infectious; C-Reactiv | 2011 |
Sternoclavicular joint septic arthritis and osteomyelitis caused by Aggregatibacter aphrophilus.
Topics: Aggregatibacter aphrophilus; Anti-Bacterial Agents; Arthritis, Infectious; Ceftriaxone; Ciprofloxaci | 2014 |
Fulminant spread of a femur anaerobic osteomyelitis to abdomen in a 17-year-old boy.
Topics: Abdominal Cavity; Adolescent; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Bact | 2012 |
Ciprofloxacin resistant osteomyelitis following typhoid fever.
Topics: Adult; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Debridement; Drug Resistance, Microbial; | 2012 |
Skull base osteomyelitis: current microbiology and management.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Anti-Infective Agents; Aspergillosis; Ceftazidime; Cipro | 2013 |
Imaging bacterial infection with (99m)Tc-ciprofloxacin (Infecton).
Topics: Abscess; Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Child; Child, Preschool; | 2002 |
Granulomatous osteomyelitis caused by bacteria other than mycobacteria: a report of two cases.
Topics: Adult; Ampicillin; Anti-Infective Agents; Ciprofloxacin; Female; Granuloma; Humans; Male; Middle Age | 2002 |
A rare case of Salmonella osteomyelitis in the humerus as a differential diagnosis to a malignant bone tumor.
Topics: Adolescent; Bone Neoplasms; Ciprofloxacin; Debridement; Diagnosis, Differential; Humans; Humeral Fra | 2002 |
Infection is not specific for bacterial osteo-articular infective pathology.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arthritis, Infectious; Child; Child, Preschool; Ciproflo | 2003 |
Treatment of post-traumatic tibial osteomyelitis using microsurgical flaps.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Bone Transplantation; Child; | 2003 |
Use of scintigraphy for assessment of fracture healing and early diagnosis of osteomyelitis following fracture repair in rabbits.
Topics: Animals; Ciprofloxacin; Female; Femur; Fracture Healing; Organotechnetium Compounds; Osteomyelitis; | 2003 |
Salmonella osteomyelitis of the thoracic spine: an unusual presentation.
Topics: Adolescent; Anti-Infective Agents; Ciprofloxacin; Female; Humans; Immunocompromised Host; Magnetic R | 2004 |
Bisphosphonate-ciprofloxacin bound to Skelite is a prototype for enhancing experimental local antibiotic delivery to injured bone.
Topics: Animals; Anti-Infective Agents; Calcium Phosphates; Ciprofloxacin; Diphosphonates; Drug Carriers; Dr | 2004 |
Prevention and treatment of experimental osteomyelitis in dogs with ciprofloxacin-loaded crosslinked high amylose starch implants.
Topics: Absorbable Implants; Amylose; Animals; Anti-Infective Agents; Ciprofloxacin; Cross-Linking Reagents; | 2004 |
Treatment of experimental osteomyelitis by liposomal antibiotics.
Topics: Animals; Anti-Bacterial Agents; Chronic Disease; Ciprofloxacin; Drug Carriers; Drug Therapy, Combina | 2004 |
Efficacy of ciprofloxacin-releasing bioabsorbable osteoconductive bone defect filler for treatment of experimental osteomyelitis due to Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Bone Cements; Ciprofloxacin; Coated Materials, Biocompatible; Diseas | 2005 |
Technetium-99m ciprofloxacin imaging in the diagnosis of postsurgical bony infection and evaluation of the response to antibiotic therapy: A case report.
Topics: Adult; Anti-Bacterial Agents; Bone Screws; Ciprofloxacin; Device Removal; Follow-Up Studies; Fractur | 2005 |
In vitro and in vivo release of ciprofloxacin from osteoconductive bone defect filler.
Topics: Animals; Anti-Bacterial Agents; Bone and Bones; Bone Substitutes; Ciprofloxacin; Delayed-Action Prep | 2005 |
[Implementation of the radiolabelled antibiotic in the detection of orthopedic infections].
Topics: Arthritis, Infectious; Bacterial Infections; Bone and Bones; Ciprofloxacin; Humans; Knee Prosthesis; | 2005 |
The preparation of ciprofloxacin hydrochloride-loaded chitosan and pectin microspheres: their evaluation in an animal osteomyelitis model.
Topics: Animals; Anti-Infective Agents; Biocompatible Materials; Calorimetry, Differential Scanning; Chitosa | 2006 |
Treatment of culture-negative skull base osteomyelitis.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Aztreonam; Ceftazidi | 2006 |
Ciprofloxacin-resistant Salmonella enterica serotype typhi in a patient with osteomyelitis of the rib.
Topics: Adult; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Male; | 2005 |
In vitro and in vivo testing of bioabsorbable antibiotic containing bone filler for osteomyelitis treatment.
Topics: Absorbable Implants; Animals; Anti-Infective Agents; Bone Substitutes; Ciprofloxacin; Disease Models | 2006 |
Ceftriaxone-resistant Salmonella septicemia and osteomyelitis in sickle cell disease adults.
Topics: Adult; Anemia, Sickle Cell; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Ciprofloxacin | 2006 |
[Temporomandibular osteomyelitis secondary to progressive necrotizing otitis externa].
Topics: Aged; Anti-Bacterial Agents; Ciprofloxacin; Gentamicins; Humans; Male; Necrosis; Osteomyelitis; Otit | 2006 |
Interleukin-1, interleukin-6, and interleukin-10 responses after antibiotic treatment in experimental chronic Staphylococcus aureus osteomyelitis.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Cefuroxime; Chronic Disease; Ciprofloxacin; Disease Models | 2006 |
Instant 99mTc-ciprofloxacin scintigraphy for the diagnosis of osteomyelitis in the diabetic foot.
Topics: Adult; Aged; Ciprofloxacin; Diabetic Foot; Escherichia coli; Humans; Middle Aged; Organotechnetium C | 2006 |
Cefotaxime-ciprofloxacin combination therapy for nontyphoid Salmonella bacteremia and paravertebral abscess after failure of monotherapy.
Topics: Abscess; Anti-Bacterial Agents; Bacteremia; Cefpodoxime; Ceftizoxime; Ciprofloxacin; Drug Therapy, C | 2006 |
A case of bilateral psoas abscesses and lumbar osteomyelitis due to recurrent salmonella infection.
Topics: Anti-Infective Agents; Ciprofloxacin; Humans; Lumbar Vertebrae; Magnetic Resonance Imaging; Male; Mi | 2006 |
Multifocal spinal and extra-spinal Mycobacterium chelonae osteomyelitis in a renal transplant recipient.
Topics: Anti-Infective Agents; Cervical Vertebrae; Ciprofloxacin; Clarithromycin; Discitis; Graft Rejection; | 2007 |
Tc-99m ciprofloxacin scans for detection of tubercular bone infection.
Topics: Adolescent; Adult; Bone Diseases; Ciprofloxacin; Diagnosis, Differential; False Positive Reactions; | 2007 |
Multiorgan involvement due to Salmonella typhi: case report.
Topics: Arthritis; Ceftriaxone; Child; Ciprofloxacin; Humans; Male; Osteomyelitis; Salmonella typhi; Typhoid | 2006 |
Efficacy of ciprofloxacin implants in treating experimental osteomyelitis.
Topics: Absorbable Implants; Animals; Anti-Infective Agents; Biocompatible Materials; Blood Platelets; Body | 2008 |
Treatment of haematogenous pyogenic vertebral osteomyelitis by single-stage anterior debridement, grafting of the defect and posterior instrumentation.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bone Transplantation; Ciprofloxacin; Debridement; Fe | 2007 |
Devastating femoral osteomyelitis after anterior cruciate ligament reconstruction.
Topics: Adult; Anterior Cruciate Ligament; Anterior Cruciate Ligament Injuries; Anti-Infective Agents; Arthr | 2008 |
Identification and control of an outbreak of ciprofloxacin-susceptible EMRSA-15 on a neonatal unit.
Topics: Abscess; Anti-Bacterial Agents; Bacteremia; Bacterial Typing Techniques; Bacteriological Techniques; | 2007 |
Salmonella gas-forming femoral osteomyelitis and pyomyositis: the first case and review of the literature.
Topics: Acinetobacter Infections; Ceftriaxone; Ciprofloxacin; Clindamycin; Cross Infection; Fatal Outcome; H | 2007 |
Flow cytometry in the diagnosis of drug-induced thrombocytopenia: two illustrative cases.
Topics: Abciximab; Angioplasty, Balloon, Coronary; Anti-Bacterial Agents; Antibodies, Monoclonal; Anticoagul | 2008 |
[Clostridium clostridiiforme vertebral osteomyelitis].
Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; Clostridium; Clostridium Infections; Drug Therapy, Comb | 2008 |
Local treatment of experimental Pseudomonas aeruginosa osteomyelitis with a biodegradable dilactide polymer releasing ciprofloxacin.
Topics: Absorbable Implants; Animals; Anti-Bacterial Agents; Ciprofloxacin; Disease Models, Animal; Drug Imp | 2008 |
Sustained release of ciprofloxacin from an osteoconductive poly(DL)-lactide implant.
Topics: Absorbable Implants; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Delayed-A | 2008 |
Pharmacokinetic study of fibrin clot-ciprofloxacin complex: an in vitro and in vivo experimental investigation.
Topics: Animals; Anti-Infective Agents; Biodegradation, Environmental; Chronic Disease; Ciprofloxacin; Drug | 1995 |
Clivus and cervical spinal osteomyelitis with epidural abscess presenting with multiple cranial neuropathies.
Topics: Abscess; Aged; Anti-Infective Agents; Ceftazidime; Cephalosporins; Ciprofloxacin; Cranial Fossa, Pos | 1995 |
Autoimmune haemolytic anaemia associated with ciprofloxacin.
Topics: Aged; Anemia, Hemolytic, Autoimmune; Bacteremia; Ciprofloxacin; Diclofenac; Female; Humans; Osteomye | 1995 |
Primary sternal osteomyelitis.
Topics: Adult; Ciprofloxacin; Clindamycin; Combined Modality Therapy; Debridement; Female; Humans; Osteomyel | 1993 |
Pubic osteomyelitis due to Pseudomonas aeruginosa.
Topics: Aged; Ciprofloxacin; Female; Humans; Osteomyelitis; Pseudomonas aeruginosa; Pseudomonas Infections; | 1993 |
The Dambusters: a case of cerebrospinal and urinary obstruction.
Topics: Aged; Catheterization; Cefuroxime; Ciprofloxacin; Escherichia coli Infections; Humans; Hydrocephalus | 1993 |
Ciprofloxacin-induced toxic epidermal necrolysis.
Topics: Administration, Oral; Adult; Ciprofloxacin; Female; Hospitals, University; Humans; Lupus Erythematos | 1993 |
Oral ciprofloxacin for treatment of chronic osteomyelitis.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Ampicillin; Bacterial Infections; Chronic Dise | 1993 |
Prosthetic hip infection and bacteremia due to Campylobacter jejuni in a patient with AIDS.
Topics: AIDS-Related Opportunistic Infections; Bacteremia; Campylobacter Infections; Campylobacter jejuni; C | 1993 |
Mycobacterium fortuitum osteomyelitis following trauma.
Topics: Accidents, Traffic; Adult; Ciprofloxacin; Debridement; Humans; Hyperbaric Oxygenation; Male; Multipl | 1993 |
Haemophilus aphrophilus discitis and vertebral osteomyelitis.
Topics: Abscess; Anti-Infective Agents; Cephalosporin Resistance; Ciprofloxacin; Discitis; Haemophilus; Haem | 1995 |
Emergence of ciprofloxacin resistance during treatment of Salmonella osteomyelitis in three patients with sickle cell disease.
Topics: Adult; Anemia, Sickle Cell; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Female | 1996 |
Osteomyelitis of the spine due to Salmonella infection--conservative treatment with quinolone: a case report.
Topics: Adolescent; Anti-Infective Agents; Ciprofloxacin; Humans; Lumbar Vertebrae; Male; Osteomyelitis; Sal | 1997 |
A relapse of paratyphoid fever after treatment with ciprofloxacin in a child with congenital biliary atresia.
Topics: Anti-Infective Agents; Biliary Atresia; Ciprofloxacin; Humans; Infant; Male; Osteomyelitis; Paratyph | 1997 |
Haemophilus aphrophilus bacteraemia complicated with vertebral osteomyelitis and spinal epidural abscess in a patient with liver cirrhosis.
Topics: Abscess; Aged; Bacteremia; Cefotaxime; Ciprofloxacin; Epidural Space; Female; Haemophilus; Haemophil | 1997 |
In vitro and in vivo release of ciprofloxacin from PLGA 50:50 implants.
Topics: Animals; Anti-Infective Agents; Biocompatible Materials; Capsules; Ciprofloxacin; Disease Models, An | 1998 |
Safety of long-term therapy with ciprofloxacin: data analysis of controlled clinical trials and review.
Topics: Arthritis, Reactive; Ciprofloxacin; Consumer Product Safety; Humans; Inflammatory Bowel Diseases; My | 1999 |
Pseudomonas osteomyelitis of the symphysis pubis after inguinal hernia repair.
Topics: Adult; Ciprofloxacin; Diagnosis, Differential; Hernia, Inguinal; Humans; Male; Osteitis; Osteomyelit | 1999 |
Reactivation of osteomyelitis caused by Staphylococcus aureus after 50 years.
Topics: Aged; Anti-Infective Agents; Antibiotics, Antitubercular; Ciprofloxacin; Femur; Humans; Male; Muscle | 1999 |
[Oral antibiotic therapy in the adult bacterial osteomyelitis: results after two years of follow-up].
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotics | 1999 |
Demonstration of spinal osteomyelitis with Ga-67 citrate, Tc-99m MDP, and Tc-99m ciprofloxacin with provisionally negative results on MRI.
Topics: Aged; Ciprofloxacin; Citrates; False Negative Reactions; Female; Gallium; Humans; Lumbar Vertebrae; | 2000 |
Mycobacterium fortuitum osteomyelitis in a peripheral blood stem cell transplant recipient.
Topics: Administration, Oral; Adult; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Biopsy; Cefoxit | 2000 |
Vertebral osteomyelitis: a rare complication of transvaginal ultrasound-guided oocyte retrieval.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Escherichia coli Infections; Female; Humans; Oocytes; O | 2000 |
Salmonella infantis osteomyelitis in sickle cell disease.
Topics: Anemia, Sickle Cell; Anti-Infective Agents; Bone and Bones; Child; Ciprofloxacin; Female; Hemoglobin | 2000 |
An unusual post-operative wound infection with Salmonella typhi: case report.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Humans; Male; Osteomyelitis; Pain, Postoperative; Salmo | 2000 |
Usefulness of 99mTc-ciprofloxacin (infecton) scan in diagnosis of chronic orthopedic infections: comparative study with 99mTc-HMPAO leukocyte scintigraphy.
Topics: Adult; Aged; Aged, 80 and over; Bacterial Infections; Bone and Bones; Child; Child, Preschool; Chron | 2001 |
A simple infection model using pre-colonized implants to reproduce rat chronic Staphylococcus aureus osteomyelitis and study antibiotic treatment.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Biofilms; Cefuroxime; Cephalosporins; Chronic | 2001 |
Tc-99m infecton and Tc-99m MDP imaging in osteomyelitis of the hip joint.
Topics: Ciprofloxacin; Diagnosis, Differential; Female; Femur Head Necrosis; Hip Joint; Humans; Middle Aged; | 2002 |
[Tc-99m ciprofloxacin in clinically selected patients for peripheral osteomyelitis, spondylodiscitis and fever of unknown origin--preliminary results].
Topics: Adult; Aged; Aged, 80 and over; Bacterial Infections; Bone and Bones; Ciprofloxacin; Diagnosis, Diff | 2002 |
Holding power of bioabsorbable ciprofloxacin-containing self-reinforced poly-L/DL-lactide 70/30 bioactive glass 13 miniscrews in human cadaver bone.
Topics: Absorbable Implants; Adult; Anti-Infective Agents; Biocompatible Materials; Bone Screws; Ceramics; C | 2002 |
Salmonella osteomyelitis in aplastic anaemia after antilymphocytic globulin and steroid treatment.
Topics: Adult; Anemia, Aplastic; Antilymphocyte Serum; Ciprofloxacin; Female; Humans; Methylprednisolone; Os | 1992 |
[Ciprofloxacin in the ambulatory treatment of osteomyelitis in diabetic foot].
Topics: Acute Disease; Aged; Ambulatory Care; Ciprofloxacin; Diabetes Mellitus, Type 2; Diabetic Angiopathie | 1992 |
Ciprofloxacin: drug of choice in the treatment of malignant external otitis (MEO).
Topics: Aged; Aged, 80 and over; Chronic Disease; Ciprofloxacin; Female; Follow-Up Studies; Humans; Male; Mi | 1991 |
Oral quinolone treatment for osteomyelitis.
Topics: Ciprofloxacin; Humans; Methicillin Resistance; Osteomyelitis; Staphylococcal Infections | 1991 |
[Ciprofloxacin and osteomyelitis caused by Pseudomonas aeruginosa].
Topics: Aged; Ciprofloxacin; Humans; Male; Osteomyelitis; Pseudomonas Infections | 1991 |
Ciprofloxacin and myasthenia gravis.
Topics: Aged; Ciprofloxacin; Humans; Male; Myasthenia Gravis; Osteomyelitis | 1990 |
Effect of ciprofloxacin on experimental osteomyelitis in the rabbit tibia, induced with a mixed infection of Staphylococcus epidermidis and Bacteroides thetaiotaomicron.
Topics: Animals; Bacteroides; Bacteroides Infections; Bone and Bones; Bone Marrow; Catheters, Indwelling; Ci | 1990 |
Ciprofloxacin-induced anaphylactoid reactions in patients infected with the human immunodeficiency virus.
Topics: Adult; Anaphylaxis; Ciprofloxacin; Female; HIV Seropositivity; Humans; Male; Osteomyelitis; Urinary | 1990 |
Oral ciprofloxacin compared with standard parenteral antibiotic therapy for chronic osteomyelitis in adults.
Topics: Administration, Oral; Adult; Aged; Chronic Disease; Ciprofloxacin; Clindamycin; Drug Therapy, Combin | 1990 |
Oral ciprofloxacin for osteomyelitis.
Topics: Administration, Oral; Adult; Aged; Ciprofloxacin; Debridement; Female; Humans; Male; Middle Aged; Os | 1990 |
Oral ciprofloxacin treatment of Pseudomonas aeruginosa osteomyelitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ciprofloxacin; Female; Humans; Male; Middle Aged; Osteom | 1990 |
Comparative efficacies of ciprofloxacin, pefloxacin, and vancomycin in combination with rifampin in a rat model of methicillin-resistant Staphylococcus aureus chronic osteomyelitis.
Topics: Animals; Chronic Disease; Ciprofloxacin; Disease Models, Animal; Drug Therapy, Combination; Male; Me | 1990 |
[Treatment with oral ciprofloxacin of pubic osteomyelitis caused by Pseudomonas aeruginosa].
Topics: Ciprofloxacin; Humans; Male; Middle Aged; Osteomyelitis; Pseudomonas Infections; Pubic Bone | 1989 |
Evaluation of pefloxacin, ofloxacin and ciprofloxacin in the treatment of thirty-nine cases of chronic osteomyelitis.
Topics: Administration, Oral; Adult; Bacterial Infections; Ciprofloxacin; Drug Evaluation; Escherichia coli; | 1989 |
Treatment of nail puncture wounds.
Topics: Animals; Child; Ciprofloxacin; Foot Injuries; Humans; Osteomyelitis; Pseudomonas Infections; Shoes; | 1989 |
Intravenous ciprofloxacin therapy in severe infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Ciprofloxacin; Female; Humans; Inf | 1989 |
Treatment of chronic osteomyelitis with ciprofloxacin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteria; Chronic Disease; Ciprofloxacin; Exudates and T | 1989 |
Oral ciprofloxacin therapy of infections due to Pseudomonas aeruginosa.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents, Urinary | 1986 |
Clinical use of the quinolones.
Topics: Anti-Infective Agents; Ciprofloxacin; Diarrhea; Enoxacin; Gastrointestinal Diseases; Humans; Naphthy | 1987 |
Open, prospective study of the clinical efficacy of ciprofloxacin.
Topics: Adolescent; Adult; Aged; Arthritis; Bacterial Infections; Ciprofloxacin; Female; Gastrointestinal Di | 1985 |
Experience with ciprofloxacin in the treatment of various infections caused mainly by Pseudomonas aeruginosa.
Topics: Abscess; Administration, Oral; Adolescent; Adult; Aged; Bronchopneumonia; Child; Ciprofloxacin; Fema | 1985 |
Evaluation of ciprofloxacin in the treatment of Pseudomonas aeruginosa infections.
Topics: Abscess; Administration, Oral; Adolescent; Adult; Aged; Anti-Bacterial Agents; Bronchopneumonia; Chi | 1986 |
[Antibiotic spongiosaplasty in the treatment of post-traumatic osteitis].
Topics: Adult; Anti-Bacterial Agents; Bone Transplantation; Ciprofloxacin; Female; Humans; Male; Middle Aged | 1986 |
Osteomyelitis of the maxilla with associated vertical root fracture and Pseudomonas infection.
Topics: Adult; Chronic Disease; Ciprofloxacin; Humans; Incisor; Male; Maxillary Diseases; Osteomyelitis; Pse | 1988 |
Ciprofloxacin as therapy for experimental osteomyelitis caused by Pseudomonas aeruginosa.
Topics: Animals; Anti-Bacterial Agents; Bone and Bones; Chronic Disease; Ciprofloxacin; Drug Resistance, Mic | 1985 |
Successful oral treatment of methicillin-resistant Staphylococcus aureus osteomyelitis using ciprofloxacin.
Topics: Ciprofloxacin; Humans; Male; Methicillin; Middle Aged; Osteomyelitis; Penicillin Resistance; Staphyl | 1988 |
Treatment of chronic osteomyelitis with ciprofloxacin.
Topics: Adult; Aged; Bacterial Infections; Chronic Disease; Ciprofloxacin; Female; Humans; Male; Middle Aged | 1987 |
Treatment of bone, joint, and soft-tissue infections with oral ciprofloxacin.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Cellulitis; Ciprofloxacin; Enterob | 1987 |
Comparative evaluation of A-56619, A-56620, and nafcillin in the treatment of experimental Staphylococcus aureus osteomyelitis.
Topics: Animals; Anti-Bacterial Agents; Bone and Bones; Ciprofloxacin; Fluoroquinolones; Nafcillin; Osteomye | 1987 |
Pharmacokinetics of ciprofloxacin in acutely ill and convalescent elderly patients.
Topics: Administration, Oral; Aged; Aged, 80 and over; Ciprofloxacin; Female; Half-Life; Humans; Kinetics; M | 1987 |
Ciprofloxacin: an overview and prospective appraisal.
Topics: Administration, Oral; Animals; Bacterial Infections; Ciprofloxacin; Cystic Fibrosis; Disease Models, | 1987 |
Treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis with ciprofloxacin or vancomycin alone or in combination with rifampin.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Drug Therapy, Combination; Osteomyelitis; Rats; Rats, | 1987 |
[Ciprofloxacin in Salmonella infection and abdominal typhoid].
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Carrier State; Ciprofloxacin; Female; Humans; Male; | 1986 |
Treatment of skin and soft tissue infections with oral ciprofloxacin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Cellulitis; Ciprofloxacin; Female; | 1986 |